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ABSTRACT 
 
The NHS is continually striving to improve patient care.  Enhanced Recovery after 
Surgery (ERAS) initiatives have been proven to benefit patient care, reduce 
complication rates and shorten length of stay. The drive is efficacy and equity of care 
for all patients.  
Originally developed in colorectal surgery and established in three other surgical 
specialities (gynaecological, urological and musculoskeletal surgery) the Department 
of Health, through the NHS Improvement framework, is driving the wider adoption of 
ERAS. The adoption of enhanced recovery principles in thoracic surgery is gathering 
pace. Birmingham Heartlands Hospital is at the forefront of driving the development 
of ERAS in thoracic surgery.  
This project will establish the evidence base for key thoracic interventions on the 
ERAS pathway, show the results of the first national survey of thoracic ERAS 
practice and highlight the preliminary achievements on patient outcomes. The project 
will also show the results of visits to other thoracic surgical units and the gap 
analyses performed on their ERAS pathways. The project will also highlight the 
construction of the first manual for ERAS in thoracic surgery and patient information 
booklet. The resulting ERAS pathway can thus be used by others within the speciality 
of thoracic surgery to promote and enhance the care of their patients. 
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1 INTRODUCTION  
 
1.1 Concept of enhanced recovery 
 
“…to enable patients to recover sooner…” 
 
Enhanced recovery after surgery (ERAS) or ‘fast-track’ surgery was originally 
pioneered in the 1990’s by Professor Henrik Kehlet in colorectal surgery [1]. By 
examining the roles of various components contributing to post-operative morbidity, 
he devised interventions to minimise the surgical stress on his patients. His 
multimodal approach was designed to reduce post-operative complications, 
facilitating earlier discharge from hospital and a reduction in healthcare expenditure. 
 
The National Health Service (NHS) is continually striving to improve patient care and 
thus started using this approach, again most prominently in colorectal surgery, from 
the early 2000’s. The clear benefits for both patients and healthcare providers 
resulted in the release of ‘Delivering enhanced recovery- helping patients to get 
better sooner after surgery’ in 2010 [2]. This document summarised the 
implementation of enhanced recovery (ER) within the NHS at that time and provided 
a road-map of how to set up an enhanced recovery pathway. For the first time it gave 
details of a generic ER pathway and the multi-step processes within it.   
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Figure 1: The original enhanced recovery pathway [adapted from ref 2] 
 
The underlying principle of ERAS is to enable patients to recover sooner by 
minimising the stress responses on the body from surgery.  But this doesn’t just 
mean having the best operation. The figure illustrates the pathway and the number of 
individual peri-operative interventions along the entire patient journey. It starts at 
referral and continues until discharge. Each step is evidence based.  
 
Successful implementation is achieved by: 
- The patient being in the best possible condition for surgery 
- The patient having the best possible management during and after their operation 
- The patient experiencing the best possible post-operative rehabilitation  
3 
  
1.2 Colorectal surgery  
The concept of ‘fast-track’ or enhanced recovery after surgery was pioneered in 
colorectal surgery. The results of enhanced recovery programmes in colorectal 
surgery have thus been evaluated in the greatest detail and have been the subject of 
several systematic reviews, meta-analyses and a Cochrane review [3-5]. For 
example standardised ER programmes encompassing pre-operative, in-hospital and 
post-operative care have been shown to result in a number of patient benefits. These 
include reduction in length of stay [5-11], reduction in morbidity [5,7,9] and promoting 
patient reported outcome measures [12], without increasing readmission rates [13-
15]. Other advantages of ER programmes over standard or traditional perioperative 
care include earlier recovery and discharge after colonic resection [1,6,9,12]. 
Two systematic reviews evaluated the effects of an ER programme as compared to 
conventional care, in terms of mortality, morbidity, length of hospital stay and rate of 
readmissions [5,16]. These two studies evaluated 4 and 6 RCTs respectively 
[7,12,17-20] and showed no differences in mortality or rate of readmission, a 
reduction in morbidity and reduced length of hospital stay for those patients in an ER 
care pathway. These findings compare favourably with a meta-analysis of the same 
RCTs which confirmed these advantages of an ER care pathway [4]. 
In addition to clinical outcomes there has also been some attempt to quantify the 
benefits of ER on health economics. Although the literature is more limited, a few 
studies have speculated there may be reduced costs associated with ER 
programmes, as complication rates and readmission rates are lower [4,21,22]. 
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This evidence has led to the construction and publication of ER programmes as 
consensus documents providing recommended guidelines for patients undergoing 
colorectal surgery [23-26]  
 
1.3 Non-colorectal surgery  
Compared to colorectal surgery, fewer studies have been conducted in other surgical 
specialities. However, since 2008, ER programmes have been reported to benefit 
patients undergoing urological, hepato-biliary, upper gastrointestinal and 
gynaecological surgery [27,30-34]. Studies have shown a reduction in length of stay 
for patients undergoing radical cystectomy [27], liver resection [28], oesophagectomy 
[29], laparoscopic gastric surgery [30] and hysterectomy [34]. Reduced pulmonary 
complications and mortality for patient undergoing oesophageal resection has also 
been shown [29], whilst for gastric resections, readmission rates have also fallen 
[30]. Some of the evidence in upper gastrointestinal surgery is conflicting. Whilst in 
principle ER has been shown to offer particular advantages, some authors have 
questioned the underlying evidence base due to the heterogeneity of reported 
studies [31,32], despite its apparent safety [32,33].  
 
1.4 Thoracic surgery  
Evidence for the benefits, or otherwise, of ER programmes in thoracic surgery is 
sparse. The adoption of ER principles and elements specifically designed for thoracic 
surgical practice has been slower. However, with the increase in lung cancer 
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prevalence, thoracic surgery is an expanding speciality. With the majority of thoracic 
surgery being elective, or non-emergency, surgery, the speciality lends itself to the 
implementation of enhanced recovery. Thus, the advantages of ER already 
demonstrated in non-thoracic surgery are starting to be implemented in thoracic 
surgery. More recently, thoracic surgery specific elements and pathways have been 
implemented [35-37]. These ER pathways have, in the main, been constructed from 
colorectal pathways, and incorporate the most suitable elements for thoracic surgery. 
Non-thoracic elements such as the routine use of bowel preparation and nasogastric 
tubes have been excluded.  
A 2016 systematic review highlighted a need for further studies to identify benefits for 
thoracic surgical patients [38]. Recent publications have shown benefits for lung 
cancer patients undergoing surgery with reduced length of hospital stay [39-41], 
reduction in surgical complications [39,41], reduced ITU admission [40,41] whilst 
being cost effective [39,40]. A further systematic review, comprising data from seven 
RCTs indicated ER patients had significantly lower morbidity rates, surgical 
complications rates, shortened hospital stay, ITU stay and reduced costs [42].  
However, at the time of writing, there are no definitively published recommendations 
or consensus opinion into the exact elements that make up a thoracic surgery 
specific ER programme.  
 
1.5 Quality improvement in healthcare  
The advantages of ER in colorectal surgery have been demonstrated and guidelines 
established. Thus, the implementation of an ER pathway into other surgical 
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specialities (e.g. thoracic surgery) should improve the quality of healthcare for 
patients undergoing non-colorectal surgery.   
Improving the quality of healthcare for patients will lead to better patient experience 
and outcomes. This can be achieved by employing a systematic approach to 
implementing change and monitoring subsequent progress. There are several 
approaches to delivering quality improvement, some borrowed from industry, but all 
have several underlying principles [43]. 
- Data and measurement for improvement: gathering data is key to 
measuring and improving quality 
- Understanding the process: process mapping can be used to identify and 
quantify problems 
- Improving reliability: ensuring reliability reduces error 
- Engagement of staff: changes to pathways or care is difficult without 
engagement of staff delivering that service, engagement with change is 
vital 
- Involving patients: patients have a role to play in designing improvements 
and also monitoring the impact of changes to healthcare 
 
For patients undergoing treatment within the NHS, a five-step improvement approach 
has been designed by NHS Improvements [44]. The five steps of each project should 
include the following phases: 
 1. Preparation- defining aims and objectives, collecting baseline data,  
 identifying team and direction of planned work 
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 2. Launch- start of project 
 3.Diagnosis- understanding the current process, using data to define the 
 problem 
 4.Implementation- tests and measures potential solutions 
 5.Evaluation- learning from process and incorporating improvement into 
 normal practice 
 
In conjunction with the Model of Improvement [Fig 2], these steps are designed to 
provide a framework for implementing change that leads to improvement. 
 
Figure 2: Model of Improvement [44]. 
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1.6 Measuring improvement 
Using the model of improvement the steps for this project include:  
PLAN: Review of literature 
DO: Gap analyses, units visits, national survey 
STUDY: Measure outcomes to evaluate pathway 
ACT: Construct ER pathway in thoracic surgery for potential national dissemination 
 
It is essential to measure outcomes to demonstrate whether any change is an 
improvement, or otherwise. Measures that demonstrate change in the literature are 
usually quantitative. Reported outcome measures for ER programmes focus on 
mortality, complications rates, length of hospital stay and readmission rates. Much 
less emphasis is placed on qualitative patient data, for example quality of life 
measurement, patient experience or acceptability of an ER pathway or individual 
elements within a programme. Data collection for this project will focus on 
quantitative outcome measures to assess the initial impact of ER- mortality, length of 
stay and post-operative pulmonary complication rates.  
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2 MATERIALS & METHODS  
Project aim:  
This project aims to develop a thoracic focused enhanced recovery 
programme from the principles set out in the ‘Delivering enhanced recovery’ 
document [2] and test the impact of its introduction 
 
2.1 Review of the literature 
• Key questions identified 
• Literature reviews of key questions 
 
The original ERAS pathway was devised for colorectal surgery and thus not all 
elements are applicable to thoracic surgery. Examination of the pathway (Figure 1) 
revealed various elements (e.g. bowel preparation, nasogastric tubes and wound 
drains) that are not routine practice in thoracic surgery. Thus, these were discarded 
from consideration for review. Furthermore, some aspects of routine thoracic surgical 
practice do not figure on the ERAS pathway but are important factors to consider. 
These include chest drain management and post-operative physiotherapy and 
mobilisation. A list of the 10 most important questions to consider was devised by the 
PGR and Lead-Supervisor (Table 1). This list is included below and includes the two 
questions (*) taken forward. 
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Table 1: Initial 10 questions/areas for research considered for literature review 
 
PRE-OPERATIVE PERI-OPERATIVE POST-OPERATIVE 
Patient pre-rehabilitation Day of surgery 
admission 
Early mobilisation 
Patient information and 
education 
Starvation and 
dehydration 
Digital drains/drain 
management* 
Pre-operative 
optimisation 
Carbohydrate loading*  
 Anaesthetic techniques 
and/or analgesia protocol 
 
 Avoiding fluid overload 
 
 
 
Two research questions to be taken forward for literature review: 
1) Chest drain management – information regarding underwater seals and digital 
drainage systems, threshold levels for chest drain removal, drain 
management, number of chest drains and the application of suction (to the 
chest drain) would be investigated. 
2) Carbohydrate loading – effects of pre-operative oral carbohydrate loading 
drinks on patient outcomes would be evaluated. 
 
2.1.1 Search strategies 
2.1.1.1 Chest drain management 
Literature search was conducted in February 2012 utilising MEDLINE, Embase and 
Cochrane databases to identify publications between 2000 and 2012. Medical 
subject headings terms were used, key words included chest tubes, thoracostomy, 
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thorax drainage, surgery, fast track and enhanced recovery and were combined 
using operations AND and OR. Publications were limited to human subjects and 
English language. The search strategy excluded studies in non-thoracic surgical 
patients (e.g. patients with respiratory disease), non-lung cancer patients, children or 
adolescent subjects and animal studies. Duplicate publications were excluded. For 
each relevant paper identified the abstract was obtained and reviewed by the PGR 
before inclusion or exclusion. Studies containing outcome measures comparing 
underwater seals and digital drainage systems, threshold levels for chest drain 
removal, drain management, number of chest drains and the application of suction 
(to the chest drain) were retained to answer the research question. The references 
from relevant articles were searched for additional publications. 
 
2.1.1.2 Carbohydrate loading 
Studies published between 2000 and 2012 were searched in MEDLINE, Embase and 
Cochrane databases when the literature search for this research question was 
undertaken in March 2012. Relevant articles were identified using the search terms 
preoperative care, energy drink, carbohydrate, dietary supplements and surgical 
patient in combination. The search utilised AND and OR operations and was limited 
to human subjects and English language. Duplicates were also excluded, along with 
studies involving non-surgical patients, non-adult patients and animal subjects. For 
each paper identified the abstract was obtained and reviewed by the PGR. The full 
article was obtained for relevant abstracts and the remainder discarded. Full articles 
were appraised in relation to answering the research question evaluating the effect of 
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pre-operative oral carbohydrate loading drinks on patient outcomes. A bibliography 
search of retained articles was also performed to obtain further relevant papers. 
 
2.2 Gap analysis 
• Thoracic surgical unit visits and gap analysis of each 
• Current enhanced recovery pathways evaluated 
• Assimilation of best practice into local protocols 
 
Three units undertaking thoracic surgery were visited as part of this thesis (Liverpool 
Heart & Chest Hospital, University Hospitals South Manchester and Bristol Royal 
Infirmary). Gap analysis of each unit’s ERAS pathway was undertaken (for each unit). 
Information was collated on the data collection template (Table 2). 
The data collection template was derived from the established colorectal ER pathway 
[2]. Each element within the three stages [pre-, peri- and post-operative] of the 
pathway was included. Exceptions removed from the template included elements not 
associated with established thoracic surgical practice. For example, the routine use 
of NGTs and pre-operative bowel preparation does not form part of routine thoracic 
surgical practice. These were thus removed. 
The gap analysis was designed to elicit the elements of ER being practiced at other 
thoracic surgical institutions, to instruct formulation of our own pathway. Due to the 
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small number of interviews conducted and the informal nature of these discussions, 
formal qualitative analysis of the data obtained was not intended.   
 
Table 2: Gap analysis template [2] 
Elements 
Practice 
status 
Notes / 
actions 
Responsibility 
Getting the patient in best possible condition 
Primary Care Input  
Optimising Haemoglobin levels    
Managing pre-existing co morbidities e.g. 
Diabetes/Hypertension 
   
Pre-operative  
Health and Risk Assessment    
Good Quality Patient Information    
Informed decision making    
Managing patient’s expectations     
Optimised health/medical condition    
Therapy Advice    
Carbohydrate loaded drinks (high energy drinks)    
Maximising patients hydration    
Discharge Planning – expected date of discharge (EDD)    
Admission  
Admit on day of surgery    
Optimise fluid hydration    
Avoid routine use of sedative pre-medication    
Carbohydrate loaded drinks (high energy drinks)    
 
 
The patient has the best possible management during surgery 
Intra-operative  
Minimally invasive surgery if possible    
Individualised goal-directed fluid therapy    
Avoid crystalloid overload    
Epidural management    
Use of regional/spinal and local anaesthetic with sedation    
Hypothermia prevention    
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The patient experiences the best post-operative rehabilitation 
Post Operative  
No routine use of wound drains    
Chest drain management    
Active planned mobilisation <24 hrs    
Early oral hydration    
Early oral nutrition    
IV therapy stopped early    
Catheters removed early    
Regular oral analgesia e.g. paracetamol and NSAIDS    
Avoidance of systemic opiate-based analgesia where 
possible 
   
Follow-up  
Discharge on planned day or when criteria met    
Therapy support (Physio, Dietician)    
24 hour telephone follow-up call if appropriate    
 
 
2.3 National survey 
• Survey construction 
The survey was constructed by the PGR and Lead-supervisor. Questions were 
derived to elicit information regarding the key elements of ER as defined by the 
review of the literature and by responses captured in the gap analysis. These were 
defined as pre-operative assessment, patient information, day of surgery admission, 
starvation instructions, the use of minimally invasive surgery, post-operative 
analgesia, physiotherapy input and post-discharge from hospital advice. The survey 
underwent a number of revisions to ensure ease of use after review from key 
stakeholders including surgeons, anaesthetists, nursing staff, physiotherapists and 
lung cancer nurse specialists It was subsequently trialled at Heart of England NHS 
Foundation Trust before national dissemination (Figure 3). 
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Figure 3: The questions posed in the survey of ER implementation. The majority of 
questions were yes/no. In some instances there were several fixed options to choose 
from. 
Authors: Mr R Wotton, Mr B Naidu 
 DEMOGRAPHICS 
1. Which unit do you work in? 
2. What is your profession? 
 
PRE-OPERATIVE ASSESSMENT 
3. Do your elective thoracic (lung) surgery patients go through a Pre-
operative assessment clinic (POAC)? 
4. If yes, what percentage of patients go through POAC? 
5. If yes, is an anaesthetist available to review patients in POAC? 
6. How do you believe a POAC benefits your patient? 
 
PATIENT INFORMATION 
7. Does each patient receive thoracic surgery-specific information? 
8. If yes, in what form does this take? 
9. How do you rate the information your unit gives to patients?  
     
DAY OF SURGERY (DOS) ADMISSION 
10. Are all elective thoracic (lung) patients admitted on DOS? 
11. If yes, what percentage are admitted on DOS?  
12. Are there any groups of patients not admitted DOS? 
13. Are there any other barriers to implementing DOS admission?  
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PERI-OPERATIVE PROCEDURES 
14. How long before surgery are your patients NBM for fluid?    
15. How long do you think your patients should be NBM for fluid pre-
operatively? 
16. How long before surgery are your patients NBM for food? 
17. How long do you think that your patients should be NBM for food pre-
operatively? 
18. Does your unit perform minimally invasive (VATS) surgery for major 
lung resections? 
19. If yes, have you observed improvements in: pain scores/complication 
rates/patient satisfaction/LOS/other? 
20. For major lung resections, for pain management, do you use: 
epidurals/PVC/intrathecal injections/IV morphine/other? 
21. What percentage of patients have a PVC for pain management?  
22. Where do your routine major lung resections go from theatre? 
 
POST-OPERATIVE PROCEDURES 
23. Does your unit have a standardised post-operative analgesia guideline? 
24. Is it a thoracic-specific written protocol? 
25. Do your analgesia guidelines include regular use of laxatives? 
26. Do your analgesia guidelines include regular use of NSAIDs? 
27. Does your unit have a standardised post-operative physiotherapy 
protocol? 
28. Is it a thoracic-specific written protocol? 
29. Are all patients with major lung resections sat out in a chair on post-
operative day 1? 
30. Do you think sitting patients out in a chair on post-operative day 1 is 
best practice?  
31. Are all patients with major lung resections mobilised on post-operative 
day 1? 
32. Do you think mobilising patients on post-operative day 1 is best 
practice? 
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DISCHARGE & FOLLOW UP 
33. Are all your patients given thoracic-specific post-discharge advice 
before going home? 
34. If yes, in what form does this take? 
35. Does your unit routinely contact patients after discharge before they are 
reviewed as an outpatient? 
36. If yes, when does this usually occur? 
37. If yes, what form does this take? 
38. How you think post discharge contact would benefit patients? 
 
 
 
A survey comprising 38 questions was sent to all thoracic surgical units (n=40) in the 
UK regarding implementation of ER. Questions were designed to survey the current 
practice and implementation of key ER elements as defined by national guidelines. 
Opinions of practice were also sought from key individuals caring for thoracic surgical 
patients from each thoracic unit with in the UK. 
 
• Recipient identification via national society database/direct contact with each 
thoracic surgical unit/email address identification on internet 
We then invited the key members of all the UK thoracic surgical Units (n= 40) to 
participate in the survey. For each unit, the opinions of surgeons, physiotherapists, 
ward nursing staff, and lung cancer specialist nurses were gathered. Responders 
were identified from a variety of sources including the professional bodies (Society 
for Cardiothoracic Surgery in Great Britain & Ireland, The National Lung Cancer 
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Forum for Nurses and The Chartered Society of Physiotherapy), the National 
Thoracic Surgery Activity & Outcomes Report [45] and information publically 
available on the internet. The aim was to encompass as wide a spectrum of opinions 
as possible, from a variety of healthcare professionals caring for thoracic surgical 
patients. The survey was completed online from a commercially available provider 
(www.surveymonkey.com). Individuals were invited to complete only once and 
responses were collected anonymously. 
 
 
• NHS Improvement involvement for survey distribution 
We sought advice from the NHS Improvements (now part of NHS IQ) on the 
questionnaire construction and clarity of survey design. 
 
 
• Collation of results 
Results were collated by NHS Improvement and conveyed to PGR and Lead-
supervisor 
 
 
• Dissemination of information at national meeting 
Presented at ERAS in thoracic surgery session entitled “Enhanced Recovery: 
Fulfilling the potential a better journey for patients and a better deal for the NHS” at 
Society for Cardiothoracic Surgery of Great Britain & Ireland, Annual Meeting 2013 
[Appendix 1]. 
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2.4 Enhanced recovery pathway development  
2.4.1 Enhanced recovery pathway at Heartlands 
 
Enhanced recovery guidelines were devised by PGR and Lead supervisor from best 
available research evidence (colorectal literature and literature review) and current 
ER practice (gap analysis) [Figure 4]. Collation of these results resulted in the 
construction of the Enhanced recovery in thoracic surgery manual.  
This was disseminated for comment and amendment by key stakeholders within 
Heartlands hospital. Opinions were sought from staff including (but not limited to) 
surgeons, anaesthetists, nursing staff, lung cancer nurse specialists, 
physiotherapists, pre-operative admission clinic staff and surgical admission suite 
staff. Feedback was incorporated into the manual before final construction and 
publication [Appendix 2]. 
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Figure 4: Flow diagram of Heartlands ER pathway design 
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2.4.2 The electronic prescription of a standardised pain control pathway 
At Birmingham Heartlands Hospital patient’s medications are prescribed 
electronically. This had previously led to the introduction of thoracic surgical 
electronic prescription (EP) bundles. These included medications for analgesia, anti-
emetics, laxatives, gastric protection, nebulisers and oxygen (Figure 5).   
 
Figure 5: Original thoracic EP bundles (Authors: Mr C Bond, Mr R Wotton, Mr B Naidu) 
 
However, these needed revising to ensure regular prescription of anti-emetics and 
laxatives to improve inpatient experience and reduce delayed discharge. Further 
modification to the bundles was proposed (Appendix 3).  
Drug group VATS (non-lobectomy) prescription 
bundle 
Thoracotomy prescription bundle 
Analgesics Paracetamol 1g QDS PO Paracetamol 1g QDS PO 
Ibuprofen 400mg TDS PO* Codeine 60mg PRN QDS PO 
Codeine 60mg PRN QDS PO  
Morphine sulphate solution 10mg hourly 
PRN PO 
Morphine sulphate solution 10mg hourly 
PRN PO 
Anti-
emetics 
Cyclizine 50mg TDS PRN PO/IM/IV Cyclizine 50mg TDS PRN PO/IM/IV 
Ondansetron 4mg QDS PRN PO/IV Ondansetron 4mg QDS PRN PO/IV 
Laxatives Docusate Sodium 100mg PRN TDS PO  Docusate Sodium 100mg PRN TDS PO 
Senna 15mg PRN Nocte PO Senna 15mg PRN Nocte PO 
Macrogol 1 sachet PRN TDS PO Macrogol 1 sachet PRN TDS PO 
Gastro-
protection 
Omeprazole 20mg OD  
Nebulisers 0.9% Salbutamol 2.5mg QDS NEB  0.9% Salbutamol 2.5mg QDS NEB  
0.9% Saline 5ml 2h PRN NEB 0.9% Saline 5ml 2h PRN NEB 
Respiratory 
depression 
Humidified oxygen (Aim sats 96%, unless 
known CO2 retainer aim 88-92%) 
Humidified oxygen (Aim sats 96%, unless 
known CO2 retainer aim 88-92%) 
Naloxone 400 micrograms PRN (If resp 
rate < 8 breaths / min) 
Naloxone 400 micrograms PRN (If resp 
rate < 8 breaths / min) 
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2.4.3 Minimising dehydration 
One of the key elements of ER is fluid management by maintaining good pre-
operative hydration. One simple strategy to minimise dehydration prior to  surgery is 
to inform patients about taking oral fluids prior to their operation. By instructing 
patient about when exactly to take oral fluids it is hoped that  dehydration can be 
avoided. This was done by reworking the patient admission letter with details of when 
the patient should have a drink. The admission letter was changed from: 
 
…You must ensure that you have nothing to eat or drink after 3.00 am on the day of 
your admission as your operation will be performed later on that day. You may have 
water until 7.00am, no gums/mints/sweets… 
to 
…You must ensure that you have nothing to eat after 3.00 am on the day of your 
admission. Please drink two large glasses of water (at least 500ml)  before 7.00am 
the morning of your surgery. Please don’t have anything to drink after 7.00am. No 
chewing gum, mints or sweets… 
By giving clear instructions to drink fluid on the morning of surgery it is hoped that 
patients are not dehydrated at time of operation 
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2.4.4 Patient information 
Another element important in any ER pathway is the provision of good quality patient 
information. The construction of a new patient information booklet was deemed 
essential to provide up to date, accurate for our own unit. Thus, drawing on the 
experience of visiting other units, evaluating their and our own patient information, 
alongside discussions with patients, ‘My Lung Surgery Handbook’ was constructed 
[Appendix 4]. This patient information booklet is currently in production and will 
shortly be distributed to lung surgery patients. 
 
2.5 Testing the pathway   
The ERAS programme was initiated at Birmingham Heartlands Hospital in February 
2013. The impact of this pathway will be assessed by a retrospective audit of 
outcomes for patients with primary lung cancer undergoing single pulmonary 
lobectomy. Patients will undergo lobectomy either by thoracotomy or VATS surgical 
approaches. Patients excluded from the analysis will include, those undergoing 
pulmonary bilobectomy, sleeve lobectomy, conversions from VATS to thoracotomy, 
redo-thoracotomy and those who had a lobectomy for non-primary lung cancer [e.g. 
benign disease or metastectomy].  
Data evaluating the impact of ERAS will be obtained for one prior to, and three years 
after the programme’s introduction. 
Patient demographics including age, sex, BMI and pre-operative FEV1 were 
collected. In addition, total number of cases per surgical approach and the outcome 
measures of number of deaths, length of hospital stay [LOS] and post-operative 
24 
  
pulmonary complications [PPC] rate were analysed. A PPC was defined as any 
patient having four, or more, of the following eight clinical, biochemical or radiological 
criteria [CXR showing evidence of atelectasis or consolidation; elevated serum WCC 
>11.2; oxygen saturations <90% on room air; purulent sputum; raised body 
temperature >38oC; microbiology reported sputum sample positive for infection; 
physician diagnosis of lower respiratory tract infection; readmission to HDU or ITU 
facilities] [46]. 
 
2.6 Data collection and analysis  
The PGR inspected the citations independently and assessed each reference for 
possible inclusion. Full text articles were obtained and the final decision over 
inclusion was made by the PGR. The methodological quality was assessed using 
Cochrane Collaboration’s tool for assessing risk of bias [47]. Data for age, BMI and 
FEV1 are presented as mean and standard deviations [SD], whilst median with 
interquartile range [IQR, 25th and 75th quartiles] are used for LOS. Statistical analysis 
package within Microsoft Excel was employed to analyse the data.  
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3 RESULTS 
3.1 Review of the literature 
• Literature review questions 
1. Chest drain management 
2. Carbohydrate loading 
 
3.1.1 Question 1- Chest drain management  
The question addressed the management of chest drains following thoracic surgery. 
A total of 291 papers were found using the reported literature searches, of which 12 
represented the best evidence to answer the questions. Two papers were found by 
bibliography searching. Figure 6 represents the selection of studies for chest drain 
management. Details of the search strategy for chest drain management are 
included in Appendix 5. 
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Figure 6: Selection of studies – chest drain management 
 
The authors, date, journal, study type, population, main outcome measures and 
results were tabulated. A number of practices regarding the management of chest 
drains following thoracic surgery were addressed, including the use of digital drains, 
drain removal threshold, the use of drain management protocols, manipulating 
intercostal drains after surgery, the number of drains placed and the routine use of 
suction (Table 3). 
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Table 3: Summary of evidence for management of chest drains 
Study Outcomes Key results 
DIGITAL v UNDERWATER SEAL DRAINAGE SYSTEMS 
Brunelli et al. 
2010 [48] 
Chest tube duration Mean ICD duration reduced with digital monitoring 4.0 vs 4.9 days 
(p=0.0007) 
Hospital stay Reduced hospital stay in digital monitoring group: 5.4 vs 6.3 days 
(p=0.007)  
Cost Cost saving of €476 per patient (p=0.008) with digital monitor (€2391 vs 
€2867) 
Filosso et al. 
2010 [49] 
First drainage (tube) 
removal day 
Earlier removal in digital group 33% vs 6% on day1 (digital 5 pts v 
traditional 1pt protocols)  for first drain (p=0.001)  
Second drainage (tube) 
removal day 
Earlier in digital group (graph data only) (p=0.005) 
Hospital LOS Reduced in digital group (graph data only) (p=0.00001) 
Overall hospitalisation 
cost 
Reduced in digital group (graph data only) (p=0.00005) 
Varela et al. 
2009 [50] 
Inter-observer 
variability: traditional 
group 
High rate of disagreement (overall kappa coefficient 0.37)  
Inter-observer 
variability: digital group  
High rate of agreement (kappa coefficient 0.88) 
DRAINAGE REMOVAL THRESHOLD 
Hessami et al. 
2009 [51] 
LOS Reduced in trial group 4.1±1.8 vs 4.8±1.7 control (p=0.04) 
Drainage time No difference: Trial 3.4±1.6 vs 3.8±1.5 control (p=0.1) 
Radiologic re-
accumulation 
No difference: Trial 8.8 vs 7.1 control (p=0.62) 
Thoracocentesis (Need 
for) 
No difference: Trial 4.3 vs 4.3 control (p=0.97) 
Decrease pulmonary 
sound 
No difference: Trial 4.4 vs 5.7 control (p=0.72) 
DRAIN MANAGEMENT PROTOCOL 
Martin-Ucar et 
al. 2003 [52] 
Compliance 95% (94 patients) with protocol 
Complications Low- 3% ICD re-insertion rate 
MANIPULATING INTERCOSTAL DRAINS 
Dango et al. 
2010 [53] 
30-day mortality No statistical difference: Milking 1.4% vs 1.4% trad (p=0.74). 
30-day morbidity No statistical difference: Milking 49% vs 53% trad (p=0.41). 
Postoperative fluid 
drainage 
Increased in milking group at 12h (p=0.03), 24h (p=0.01), 48h (p=0.004) 
post operatively than in observation group. At 2h and total drainage did 
not differ significantly.  
Duration of chest 
drainage 
No statistical difference (No data) 
Quality of effusion No statistical difference (No data) 
Postoperative air 
leakage 
No statistical difference: Milking 64% vs 65% Observation (p=0.31) 
LOS (days) No statistical difference: Milking 13.4 days vs 13.2 days (p=0.74) 
INTERCOSTAL DRAINS: ONE vs TWO 
Okur et al. 2009 
[54] 
Total pleural drainage 
(cc) 
Reduced in single ICD patients 600±43cc vs 896±56 cc [double tube] 
(p<0.001) 
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‘Early’ and ‘late’ 
postoperative pain (1-
10) 
Both reduced in single ICD group: Early- 4.28±0.21 vs 5.10±0.23 [double 
tube] (p=0.014); Late- 1.48±0.13 vs 2.00±0.17 [double tube] (p=0.01) 
Duration of chest tube 
drainage (day) 
Shorter in single group (not significant): 3.38±1.36 vs 3.90±1.46 [double 
tube] (p=0.069) 
LOS Shorter in single ICD group (not significant): 4.84±1.20 vs 5.20±1.38 
[double tube] (p=0.17) 
Complication rate No difference: Single 13 patients  vs 16 patients double tube (p=0.50) 
Dawson et al. 
2010 [55] 
 
Postoperative pain Reduced with one ICD 
Lower use of non-
standard analgesia, with 
no difference in total 
pain score. 
One ICD 
Shorter duration of 
opioids and NSAIDs 
One ICD 
Duration and amount of 
drainage 
No difference 
LOS No difference 
INTERCOSTAL DRAINS: ONE vs NONE 
Luckraz et al. 
2007 [56] 
 
Day 1 postoperative 
pain scores 
No significant difference: median score 5 (with ICD) vs 5 (no ICD) (p=0.81) 
Wound complications No difference (no data) 
Significant PTX No difference (no data) 
Small, clinically not 
significant (size <10%) 
PTX 
28% (with ICD) vs 15% (no ICD) (p=0.24) 
LOS Median LOS: 3 (with ICD) vs 1 (no ICD) day (p<0.001) 
Koc et al. 2010 
[57] 
No air leak No ICD favoured- reduced LOS, complications 
SUCTION vs NO SUCTION 
Sanni et al. 2006 
[58] 
Reduction in incidence 
of air leak 
Evidence favours underwater seal over suction. 
Prokakis et al. 
2008 [59] 
Time between removal 
of first and second ICDs 
(mean) 
No difference: Suction 1.9 and 3.1days vs 1.5 and 3days [no suction] 
(p>0.05) 
Mortality (No. deaths) No difference: 1 (suction) vs 3 (no suction) groups (p>0.05) 
Morbidity No difference (p>0.05) 
Adequacy of drainage No difference: Suction 94% vs 88.6% [no suction] (p>0.05) 
LOS (mean ± SD) No difference: Suction group 11.2 ±5.4 vs 10.3±4.5 [no suction] (p>0.05) 
 
 
Studies were also examined for possible sources of bias, but the wide variety of 
chest drain management practices between scientific papers prevented further 
evaluation in the form of a meta-analysis (Table 4). 
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Study  Year  Study type Participants (n) Potential sources of bias 
Brunelli 
[48] 
2010 RCT 159 Unblinded – performance and 
detection bias 
Filosso 
[49] 
2010 RCT 31 Unblinded – performance and 
detection bias 
Varela [50] 2009 RCT 61 Unblinded – performance and 
detection bias 
Hessami 
[51] 
2009 RCT 138 Not randomised – selection bias 
Martin-
Ucar [52] 
2003 Cohort study 99 Performance bias 
Dango [53]  2010 Cohort study 145 Not randomised – selection bias 
 
Okur [54] 2009 RCT 100 Unblinded – performance and 
detection bias 
Not randomised – selection bias 
Dawson 
[55] 
2010 Best evidence 
topic 
660 Possible reporting bias 
Luckraz 
[56] 
2007 RCT  37 Selection bias due to small sample 
size 
Koc [57] 2010 Best evidence 
topic 
974 Possible reporting bias 
 
Sanni [58] 2006 Best evidence 
topic 
694 Possible reporting bias 
 
Prokakis 
[59] 
2008 RCT 91 Unclear 
 
Table 4: Study design and bias assessment – chest drain management 
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DIGITAL v UNDERWATER SEAL DRAINAGE SYSTEMS 
Digital drainage system – drainage system encompassing a digital display showing 
current and long-term air leak, built in suction and fluid collection cannister, in one 
portable unit. 
Underwater seal – drainage system comprising chamber(s) with water seal and 
drainage collection chamber. 
 
Brunelli et al. [48] conducted a prospective randomised trial to compare digital chest 
drain system and traditional underwater seal.  One hundred and sixty-six patients 
undergoing pulmonary lobectomy were included. Chest tube duration, length of 
hospital stay and cost were the endpoints evaluated. Mean chest tube duration was 
reduced with digital chest drain system to 4.0 from 4.9 days (p=0.0007). Further 
advantages in reduced length of stay (5.4 v 6.3 days; p=0.007) and cost saving 
(€476/patient; p=0.008) were observed in patients using digital drainage monitors. 
 
Filosso et al. [49] performed pulmonary lobectomies on 31 patients with moderate 
COPD for primary lung cancer. A digital chest drainage system was compared to 
traditional underwater seal. Removal of drainage tubes was earlier in the digital 
system group with first drain removed on day 1 in 33% digital group v 6% traditional 
group (p=0.001) and second drainage tube also removed earlier (graph data; 
p=0.005). Patients in digital system group also had a shortened in-hospital length of 
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stay (graph data; p=0.00001) with a concurrently overall lower hospitalisation cost 
(graph data; p=0.00005). 
 
Varela et al. [50] undertook a prospective randomised trial comparing digital chest 
drainage system to traditional underwater seal in 61 patients undergoing pulmonary 
resection (not including pneumonectomy). Inter-observer variability in air leak 
measurement in deciding chest tube removal was evaluated. A high rate of 
disagreement (overall kappa coefficient 0.37) was observed in the traditional 
drainage system group. In contrast, in the digital system group there was a high rate 
of agreement (kappa coefficient 0.88) in deciding chest tube removal. 
 
DRAINAGE REMOVAL THRESHOLD 
Hessami et al. [51] compared chest drain output of 150ml/day and 200ml/day in 138 
patients requiring an intercostal drain for trauma or malignancy. Endpoints included 
length of hospital stay, drainage time, radiological evidence of re-accumulation, need 
for thoracocentesis and decreased pulmonary sound. Length of stay was reduced in 
the trial group: 4.1±1.8 days vs. 4.8±1.7 days in the control group (p=0.04). All other 
endpoints showed no significant difference between the two groups. The authors 
conclude using a daily drainage threshold of 200ml safely decreases LOS. 
Other studies have used a variety of different drainage thresholds: 200ml/day [48, 49, 
52, 58], 250ml/day [50, 53], 400ml/24hrs [51] without documented complication. 
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DRAIN MANAGEMENT PROTOCOL 
Martin-Ucar et al. [52] conducted an institutional review of implementation of a drain 
management protocol to test compliance and complication rate. The authors 
concluded that the protocol can be implemented with high-compliance and low 
complications. 
 
DRAIN MANIPULATION 
Dango et al. [53] investigated the effect of chest drain ‘milking’ (1 minute every 2 
hours for first 48 hours) in 145 patients undergoing pulmonary resection via 
thoracotomy. Endpoints measured included 30-day morbidity and mortality, post-
operative fluid drainage, duration of chest drainage, quality of effusion, post-operative 
air leak and length of hospital stay. ‘Milking’ or drain manipulation did not adversely 
affect 30-day mortality (p=0.74) or 30-day morbidity (p=0.41). It did significantly 
increase post-operative drainage at 12 hours (p=0.03), 24 hours (p=0.01) and 48 
hours (p=0.004) after surgery. Total drainage, and drainage at 2 hours post 
procedure, did not differ. There was no statistical difference between drain 
manipulation and observation group in terms of duration of chest drainage and 
quality of effusion (data not presented). There was also no statistical difference in 
post-operative air leak (p=0.31) and length of stay (p=0.74) between the two arms of 
the study. The authors concluded that post-operative morbidity and mortality was not 
improved with milking and should therefore not be recommended. 
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NUMBER OF DRAINS: 2 vs 1 
Okur et al. [54] undertook a prospective randomised study in 100 consecutive 
lobectomy or bi-lobectomy patients to investigate whether two chest tubes were more 
effective than one. Total pleural drainage, ‘early’ and ‘late’ post-operative pain, 
duration of chest tube drainage, length of hospital stay and complication rates were 
evaluated. Pleural drainage was reduced in single ICD patients 600±43cc vs 896±56 
cc [double tube] (p<0.001). Using only one ICD also conveyed advantages in 
reducing ‘early’ (p=0.014) and ‘late’ (p=0.01) post-operative pain. Duration of chest 
drainage was shorter in single ICD group, but not significantly, 3.38±1.36 days [single 
tube] vs 3.90±1.46 days [double tube] (p=0.069). Length of stay was shorter, 
although not significantly (p=0.17) in the single ICD group. Complication rates were 
not significantly different between the two groups (p=0.50). The authors conclude 
inserting two ICDs is no more effective than one, after standard lobectomy. Placing 
one ICD results in less postoperative pain and pleural fluid loss, without increasing 
complication rates. 
 
Dawson et al. [55] conducted a best evidence topic comparing one with two ICDs 
following lobectomy. This mini-systematic review concluded two drains were not 
superior to one, may cause more pain and be more expensive. A single ICD 
conveyed advantages in terms of lower use of non-standard analgesia with shorter 
duration of opioid and NSAID use. 
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NUMBER OF DRAINS: 1 vs 0 
Luckraz et al. [56] reported a prospective randomised trial in 60 patients placing 
either one or no ICD following VATS lung biopsy. There was no air leak at the end of 
the procedure. There was no significant difference in day 1 post-operative pain 
scores (p=0.81). There was no reported difference in wound complications or 
significant pneumothorax (no data) post procedure. Small, clinically insignificant, 
pneumothoraces were observed in both groups, 28% with ICD and 15% without ICD 
(p=0.24). Length of stay was significantly reduced in patients without ICD, 1 day vs 3 
days with ICD (p<0.001). At 6 weeks all patients had fully expanded lungs. The 
authors conclude that there is no need for ICD in patients undergoing VATS lung 
biopsy with no air leak at time of surgery. 
 
Koc et al. [57] undertook a best evidence topic comparing one to no ICD post VATS 
lung biopsy in patients without intra-operative air leak. The results of this mini-
systematic review favoured not placing an ICD, as it conveyed advantages of 
reduced length of stay and complication rate. The authors comment that where no air 
leak is detected intra-operatively, no ICD should be placed for patients undergoing 
VATS lung biopsy. 
 
SUCTION vs NO SUCTION 
Sanni et al. [58] report a best evidence topic comparing application of suction to 
underwater seal post lobectomy. The evidence favours underwater seal over suction 
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to reduce the incidence of air leak. Some studies used short term suction in the 
immediate post-operative period, with no difference in outcome. The exceptions to 
this may be patients with large air leaks or large PTX. 
 
Prokakis et al. [59] undertook a prospective randomised trial comparing active 
suction (-15 to -20 cmH2O) applied to underwater seal to no suction. The study 
included 91 patients undergoing lobectomy or bilobectomy for lung cancer. There 
was no statistical significant difference between the suction and non-suction groups 
for any of the following variables: time between removal of first and second ICDs, 
mortality, morbidity, adequacy of drainage and length of hospital stay. The authors 
conclude routine application of suction is not necessary. Suction may be useful in 
other settings (e.g. persistent PTX), but is no help when the lung is expanded. 
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3.1.2 Question 2- Carbohydrate loading  
The question addressed the effect of carbohydrate (CHO) drink supplementation on 
patient outcomes following lung resection (non-oesophageal thoracic surgery). A total 
of 42 papers were found using the reported literature searches, and bibliography 
searching, of which 8 represented the best evidence to answer the question. No 
papers were found specifically addressing the question in thoracic surgery. Studies 
selected for analysis are included in figure 7, whilst the details of the search strategy 
are included in Appendix 5. 
 
 
Figure 7: Selection of studies – carbohydrate loading 
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Evidence has been gathered from other surgical specialities. The authors, date, 
journal, study type, population, main outcome measures and results were tabulated. 
A number of prospective randomised control trials highlight the benefit of CHO 
drinks: reduced time to passage of first flatus/stool, improved grip strength, reduced 
post-operative muscle loss and reduced length of stay. The results from only a single 
study disagree with these advantages. In non-thoracic surgery, the use of CHO 
drinks appears to convey a number of advantages to patients undergoing elective 
surgery (Table 5). 
 
Table 5: Summary of evidence for carbohydrate loading 
Study  Outcomes Key result 
Hendry et al. 
2010 [60] 
 
Return of 
gastrointestinal 
function (passage of 
flatus/stool) 
[median (IQR)] 
Overall median was 5 (4-6) days. 
CHO group: trend towards shorter time 4 (3-5) vs 5 (4-7) days (p=0.076). 
Laxative group: significantly reduced time 4 (3-5) vs 5 (4-6) days (p=0.034) 
Combination group: significantly reduced time 3 (3-4) vs 6 (4-7) days 
(p=0.013) 
Gastric emptying 
(isotope breath test 
day 3 post procedure) 
Median post-operative gastric emptying was 0.74 (0.46-1.41) hours (No 
significant difference between groups; p-value not reported). 
Post-operative oral 
nutritional intake 
Oral intake >50% of nutritional requirement- median 1 (1-2) days (No 
significant difference between groups; p-value not reported). 
Functional recovery Median time to functional recovery was 4 (IQR 3-5) days (No significant 
difference between groups; p-value not reported). 
Morbidity 25% overall (No significant difference between groups; p-value not 
reported). 
LOS Initial LOS median 6 (IQR 4-7) days (No significant difference between 
groups; p-value not reported). 
Mathur et al. 
2010 [61] 
Fatigue (VAS score) 
 
Significantly higher (p<0.005) in both groups on days 1-5 after surgery. No 
significant difference between two groups (p value not reported) 
Open surgery, no epidural: fatigue score dropped to baseline by day 3 
(CHO), but still higher than baseline (p=0.008) on day 6 in placebo group 
(p=0.015 vs CHO group) 
Clinical outcomes LOS, median (range): CHO 7 (2-35), placebo 8 (2-92); p=0.344 
Open surgery without epidural CHO LOS 7 (3-11) and placebo 9 (2-48); 
p=0.054 
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Postoperative infective complications: CHO (33%) vs placebo (41%); 
p=0.387  
Discomfort Significantly higher than baseline in both groups on days 1-6 after surgery 
(p<0.007), but did not differ between groups (data not shown). By day 7 
scores had returned to baseline 
Biochemistry 
 
No significant differences in glucose, insulin and CRP between two groups 
on any day. 
Grip strength and mid-
arm muscle 
circumference (MAMC) 
Grip strength: Reduced on day 0 and over first week after surgery (p<0.10) 
in both groups. Return to baseline by day 28 
Total body protein 
(TBP) 
TBP decreased after surgery in both groups (non-significant change) 
Noblett et al. 
2005 [62] 
 
Time to first flatus 
 
Median: 2 days (CHO) vs 3 days (water; p=0.13) vs 3 days (fasting ; p=0.13) 
First bowel movement Median: 2 days (CHO) vs 3.5 days (fasting, p=0.2) vs 5 days (water, p=0.06) 
LOS 
 
Median LOS: 7.5 days (CHO) vs 13 days (water; p=0.019) vs 10 days (fasting; 
p=0.06). Water vs fasting (p>0.25) 
Grip strength Fasting group reduced post-operative grip strength (p<0.05). Median drop 
10% at discharge in fasting group compared to 8% (water; p=0.7) and 5% 
(CHO; p=0.6) 
Yuill et al. 2005 
[63] 
 
Loss of muscle mass 
(arm muscle 
circumference) 
Significantly greater loss in control group (control: -1.1±0.15cm vs CHO: -
0.5±0.16cm; p<0.05) 
Insulin control Baseline insulin levels were comparable (control: 20.7±4.9mU/l vs CHO: 
24.6±6.2mU/l). Did not differ post-operatively. 
Glucose control Baseline glucose levels were comparable (control: 6.0±1.4mmol/l vs CHO: 
5.7±1.4mU/l). Did not differ post-operatively. 
Morbidity 6 patients in each group. 
LOS Median LOS in control group was 10 days (IQR=6) and 8 days in CHO group 
(not significantly different; no p-value reported). 
Smedley et al. 
2004 [64] 
 
Post-operative change 
in body weight 
Only patients in SS group gained weight pre-operatively, but also lost 
significantly less weight  over course of study compared with CC or CS 
groups (p<0.05) 
Complications 
 
Rate of major complications was similar in the four groups. Fewer minor 
complications in the SS and CS groups than in CC group (p<0.05) 
LOS No significant differences (data not shown). 
Nutritional status No significant differences (data not shown). 
QoL (Short Form 36, 
EuroQoL 
No significant differences (data not shown). 
Cost of care Overall costs in three supplemented groups less than no-supplemented 
group (approx. £300 or 15% per patient episode; not significant). 
Brady et al. 
2003 [65]  
Shortened fluid fast No evidence of increased risk of aspiration, regurgitation or related 
morbidity 
Volume of gastric 
contents 
Water group had modest and clinically insignificant (6mls) 
Hausel et al. 
2001 [66] 
Inability to concentrate Increasing trend (p<0.05) in fasted and placebo groups from control to 
90mins 
Malaise Decreasing trend (p<0.01) in placebo and CHO groups from control to 
90mins 
Nausea Increasing trend (p<0.05) in placebo groups from control to 90mins 
Tiredness Increasing trend (p<0.05) in fasted and placebo groups from control to 
90mins 
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Unfitness Decreasing trend (p<0.01) in placebo and CHO groups from control to 
90mins 
Weakness Increasing trend (p<0.05) in fasted groups from control to 90mins 
Aspirated GFV, mL 
(median + IQR) 
 
Lap. chole: CHO vs placebo vs fasted- No difference [18 (22-41) vs 20 (10-
35) vs 24 (15-40)] 
MCS: CHO vs placebo vs fasted- No difference [2.1 (1.7-2.4) vs 1.9 (1.6-2.5) 
vs 2.0 (1.7-4.0)] 
Gastric pH (median + 
IQR) 
Lap. chole: CHO vs placebo vs fasted- No difference [2.0 (1.6-2.7) vs 1.9 
(1.8-2.3) vs 1.9 (1.6-2.3)] 
MCS: CHO vs placebo vs fasted- No difference [2.1 (1.7-2.4) vs 1.9 (1.6-2.5) 
vs 2.0 (1.7-4.0)] 
Drink related 
complications 
No cases of pulmonary aspiration or other drink-related complications 
before, during or after surgery 
Hunger Significant (p<0.05) reduction CHO vs fasting at 0,40,90mins post drink 
Thirst Significant (p<0.05) reduction CHO vs fasting at 0,40,90mins post drink 
Anxiety Significant (p<0.05) reduction CHO vs fasting at 0,40,90mins post drink 
Macfie et al. 
2000 [67] 
Weight loss Less weight loss in Group I than II, III or IV (not significant; p-value not 
reported) 
Mean serum albumin 
 
Fall observed in mean perioperative serum albumin 5-8 g/L across four 
groups (not significant; p-value not reported) 
Mean mid-arm muscle 
circumference 
No differences observed (p-value not reported) 
Mean hand grip 
strength 
No differences observed (p-value not reported) 
Postoperative 
complications 
No differences observed (p-value not reported) 
Mortality No differences observed (p-value not reported) 
Hospital LOS No differences observed (p-value not reported) 
HAD score No differences observed (p-value not reported) 
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Table 6: Study design and bias assessment – carbohydrate loading 
Study  Year  Study type Participants (n) Potential sources of bias 
Hendry 
[60] 
2010 RCT 68 No placebo available – study patients 
unblinded to intervention 
Mathur 
[61] 
2010 RCT 142 Variety of surgery procedures within 
trial–  possible confounding  
Randomisation stratified to type of 
surgery 
Noblett 
[62] 
2005 RCT 36 Small sample size in each arm 
Study patients unblinded to 
intervention 
Yuill [63] 2005 RCT 65 Method of randomisation unclear 
  
Smedley 
[64] 
2004 RCT 179 Study patients unblinded to 
intervention 
Method of randomisation unclear 
Brady [65] 2003 Cochrane review 2270  
 
Hausel 
[66] 
2001 RCT 252 Method of randomisation unclear 
Variety of surgery procedures within 
trial–  possible confounding  
Macfie [67] 2000 RCT 100 Unblinded trial 
Patients pre-selected in clinic – 
possible selection bias 
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Hendry et al. [60] conducted a prospective randomised control trial in 74 patients 
undergoing liver resection for benign and malignant disease. Patients were managed 
with an ERAS protocol and randomised to one of 4 study groups (1) Control (2) 
Laxatives (3) CHO drinks (4) Combination [laxatives + CHO drinks]. Endpoints 
included return of gastrointestinal function (passage of flatus/stool), gastric emptying 
(isotope breath test day 3 post procedure), time to post-operative oral nutritional 
intake, time to functional recovery, morbidity and LOS. Overall, the median return of 
gastrointestinal function was 5 (4-6) days. However, in the CHO group there was a 
trend towards shorter time; 4 (3-5) vs 5 (4-7) days (p=0.076). Similarly, for patients in 
the laxative group there was also significantly reduced time: 4 (3-5) vs 5 (4-6) days 
(p=0.034). The combination group also had a significantly reduced time of 3 (3-4) vs 
6 (4-7) days (p=0.013) to passage of first stool. Median post-operative gastric 
emptying was 0.74 (0.46-1.41) hours (no significant difference between groups; p-
value not reported). Time to oral nutritional intake of >50% of nutritional requirement 
was 1 (1-2) days (median [IQR] with no significant difference between groups. 
Median time to functional recovery was 4 (IQR 3-5) days (no significant difference 
between groups). The overall morbidity was 25% (no significant difference between 
groups). The median initial LOS was 6 (IQR 4-7) days (no significant difference 
between groups). The authors conclude that laxative and combination groups 
significantly decreased time to first passage of stool. There was no evidence of 
interaction between CHO drink and laxative. This study reports a significantly shorter 
median LOS as compared to other studies. Of note, the authors report no conflicts of 
interest, but the CHO drinks were provided by a pharmaceutical company in this 
study. 
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Mathur et al. [61] conducted a double blind randomised control trial comparing CHO 
drink with placebo in 142 patients undergoing elective colorectal or liver surgery. The 
prescription of a CHO drink was advantageous in reducing fatigue in patients having 
open surgery without epidural anaesthesia, but not comparing the overall groups. 
There was no statistical difference when comparing CHO drink to placebo in LOS, 
post-operative infectious complications, discomfort scores, biochemistry, grip 
strength, mid-arm muscle circumference and total body protein. The study was only 
powered to detect a 2-day reduction in LOS, which might account for the non-
significant result. There were some differences in patient characteristics, the M:F 
ratios in the two arms of study were very different and the surgery included a 
heterogenous group of procedures. The participants also reported side effects of 
CHO drinks (29%) and placebo drink (10%) at different rates.  
 
Noblett et al. [62] performed a randomised controlled trial comparing peri-operative 
CHO drink to water supplementation and fasting. Median time to first flatus was 
significantly reduced in favour of CHO drinks (2 days) when compared to water 
supplementation (3 days; p=0.13) and fasting (3 days; p=0.13). There was a non-
significant trend towards earlier first bowel movement in CHO drink group (2 days) 
when compared to fasting (3.5 days; p=0.2) and water (5 days; p=0.06). LOS was 
significantly reduced in CHO group (7.5 days) when compared to water 
supplementation (13 days; p=0.019) and fasting (10 days; p= 0.06). There was no 
significant difference between the water and fasting groups (p>0.25). Complication 
rates varied between the three groups. In the fasting group, one complication was 
reported; diarrhoea and vomiting day 8 post procedure. In the water group there were 
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three complications, one perineal wound breakdown, one anastomotic leak and one 
prolonged ileus. In the CHO group, one patient suffered from prolonged nausea and 
one further patient developed symptomatic atrial fibrillation after omission of their 
prescribed B-blocker medication. Rate control was established with 
recommencement of their own medication. 
 
Yuill et al. [63] conducted a double-blind randomised comparing peri-operative 
administration of CHO drink (12.6g/100ml) to placebo (control group). Sixty-five 
patients completed the study having undergone major, elective abdominal surgery. 
Endpoints measured included muscle mass (arm muscle circumference), insulin and 
glucose control, morbidity and LOS. There was significantly greater loss of muscle 
mass in control group (control: -1.1±0.15cm vs CHO: -0.5±0.16cm; p<0.05). Baseline 
insulin levels were comparable (control: 20.7±4.9mU/l vs CHO: 24.6±6.2mU/l) and 
levels did not differ post-operatively. Baseline glucose measurements were 
comparable (control: 6.0±1.4mmol/l vs CHO: 5.7±1.4mU/l) and did not differ post-
operatively. Morbidity included 6 patients in each arm of the study. The median LOS 
in control group was 10 days (IQR=6) and 8 days in CHO group (not significantly 
different; no p-value reported). 
 
Smedley et al. [64] conducted a two-phase randomised trial comparing the use of 
CHO drinks before and after surgery, in four groups (SS, SC, CS, CC; 
S=supplements, C=no supplements; taken in phases I & II). The primary endpoint 
was change in post-operative body weight. Only patients in SS group gained weight 
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pre-operatively, but also lost significantly less weight  over the course of the study 
compared with CC or CS groups (p<0.05). Secondary endpoints included 
complication rate, LOS, nutritional status, QoL and cost of care. The rate of major 
complications was similar in the four groups. There were fewer minor complications 
in the SS and CS groups than in CC group (p<0.05). Overall costs in the three 
supplemented groups were less than in the no-supplemented group (approx. £300 or 
15% per patient episode) but this saving was not statistically significant. Changes in 
LOS, nutritional status and QoL were not significant (data not shown). The authors 
conclude that the use of peri-operative CHO supplements has no disadvantages, 
leads to clinical benefit and is cost-effective in patients undergoing moderate to major 
lower gastrointestinal tract surgery. 
 
Brady et al. [65] performed a Cochrane review of peri-operative fasting to prevent 
peri-operative complications. Fluids given up until 2 hours before surgery included 
CHO drinks. The authors conclude that shortening the fluid fast before surgery does 
not increase the risk of aspiration, regurgitation or related morbidity. Thus, the 
traditional view of ‘nil-by-mouth from midnight’ needs review as giving hydration is 
advantageous for the patient in preventing thirst and prolonged starvation. 
 
Hausel et al. [66] conducted a randomised double-blinded control trial using the CHO 
drinks compared to placebo and a control group. The study was conducted in 252 
patients undergoing elective laparoscopic cholecystectomy and major colorectal 
surgery. Patients with ASA 3 or greater and diabetics were excluded. Three groups 
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were compared: CHO (800ml the night prior to surgery + 400ml in the morning) 
versus placebo (identical taste and volume) versus fasting from midnight. Visual 
analogue scales were recorded at 4 time-points (baseline, prior to CHO drink, 40mins 
+ 90mins after morning drink) for a number of outcome measures. The CHO drink 
increased well-being compared with placebo or fasting. It was also more effective 
than placebo in reducing hunger, thirst and anxiety, without increasing gastric 
volumes or acidity. The authors concluded that peri-operative discomfort could be 
reduced in a majority of patients with use of a CHO drink. 
 
Macfie et al. [67] undertook an un-blinded randomised control trial in 100 patients 
undergoing elective major gastrointestinal surgery. The study comprised two phases, 
an outpatient pre-operative phase and inpatient post-operative phase. Patients were 
randomised to one of four groups:  I-Pre & post-op supplements, II- pre-op 
supplements only, III- post-op supplements only or IV- no supplements. Endpoints 
included weight loss, mean serum albumin, mean mid-arm muscle circumference, 
mean hand grip strength, postoperative complication rate, mortality, hospital LOS 
and HAD score. There was less weight loss in Group I than II, III or IV (not significant; 
no p-value reported). A fall was observed in mean peri-operative serum albumin 5-8 
g/L across four groups (not significant; no p-value reported). There was no observed 
difference between groups for the remaining outcomes measures (p-values not 
significant). The authors conclude that the routine use of perioperative CHO drinks in 
well-nourished patients confers no clinical or functional benefit. 
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3.2 Gap analysis 
A gap analysis of ER elements was conducted at Birmingham Heartlands Hospital 
with additional visits to two further thoracic surgical units. These unit visits were 
designed to evaluate the implementation of ER in two other large thoracic surgical 
units. The visits included interviews with key members of local teams providing 
enhanced recovery. Results of these visits, gap analyses and interviews have been 
integrated into the construction of the enhanced recovery in thoracic surgery pathway 
at Heartlands Hospital.  
 
1: Birmingham Heartlands Hospital 
Although not a formalised ER programme, Heartlands hospital already has many 
elements in place for thoracic surgical patients. These include a well-established pre-
habilitation programme, POAC, DOSA and robust early mobilisation practices with 
active daily physiotherapy input. The implementation of minimally invasive surgery is 
also increasing, although it is not yet well established. 
 
2: University of South Manchester [UHSM] 
On visiting UHSM discussions were had with the ER lead nurse across the hospital 
site. Having an ER leader was advantageous in facilitating the implementation ER, 
even if it did not yet include thoracic surgery. Pioneering ER came from non-thoracic 
surgical specialities, particularly colorectal and urology. ER elements at UHSM 
included a robust POAC and a nurse led post discharge follow up service. There 
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were however no patients admitted on DOS, no standardised analgesia protocol or 
routine use of digital drains to aid early mobilisation. 
 
3: Bristol Royal Infirmary 
This unit leads the UK in ER in thoracic surgery. All elements of ER are employed 
including an established POAC, the routine use of CHO loading supplements, DOSA, 
minimally invasive surgery, the use of digital drains to facilitate early post-operative 
mobilisation, a structured analgesic protocol and post discharge follow up. The only 
element not available to thoracic patients was pre-operative optimisation in the form 
of pre-habilitation,  
 
The data from each unit analysis is summarised below in Table 7 [Full details of each 
unit visit - Appendix 6]. 
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Table 7: Gap analysis - Summary data  
Elements 
 
BIRMINGHAM MANCHESTER BRISTOL 
Getting the patient in best possible condition 
Primary Care Input  
Optimising Haemoglobin levels No No POAC identifies 
problems 
Managing pre-existing co 
morbidities e.g. 
Diabetes/Hypertension 
No No POAC identifies 
problems 
Pre-operative  
Health and Risk Assessment POAC Verbal by LCNS e.g. 
surgery info/VTE 
OPC+POAC same 
day 
POAC has on 
hand anaesthetic 
consultants to 
review pts 
Good Quality Patient Information POAC- quantity (too 
much) and quality (too 
detailed)  
Verbal by LCNS e.g. 
surgery info/VTE 
Patient diary 
EDD given 
Informed decision making Discussion in OPC Verbal discussion 
LCNS/OPC 
Consent form 
(unsigned) given to 
patient to take 
home and read. 
Brings on DOSA 
Managing patient’s expectations of 
what will happen to them 
??? Verbal discussion 
LCNS/OPC 
See above 
Optimised health/medical condition ??? Too late  
Therapy Advice ???   
Carbohydrate loaded drinks (high 
energy drinks) 
No No – no access Yes. 2/7 pre-
surgery 
High CHO on day 
of surgery 
7/7 post surgery 
Maximising patients hydration ? Patient information 
may lead to excess 
dehydration 
No Can drink water 
until 2hrs prior to 
surgery 
Discharge Planning – expected 
date of discharge (EDD) 
? Given Yes Given to patient in 
OPC 
Admission  
Admit on day of surgery Yes No – night before Yes - routine 
Optimise fluid hydration Unclear- ?dehydrated 
prior to surgery. No 
pre-op drinks or 
hydration 
None Water until 2hrs 
prior to surgery 
Avoid routine use of sedative pre-
medication 
Yes Yes Yes 
Carbohydrate loaded drinks (high 
energy drinks) 
No No Yes 
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Getting the patient in best possible condition: 
 
Even within the three units evaluated there is a wide variety in practice prior to 
surgery. The time between the patient’s review in outpatient clinic and operation is 
short, often one to two weeks. All three units have robust pre-operative assessment 
clinic (POAC) to identify potential issues and prepare the patient for surgery. Key 
information is given in outpatient clinic (OPC) or POAC, so that the patients can be 
admitted on the day of their operation in Birmingham and Bristol. Only Bristol patients 
receive carbohydrate (CHO) drinks, one of the ER interventions identified from other 
surgical specialities programmes.  
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Elements BIRMINGHAM MANCHESTER BRISTOL 
 
The patient has the best possible management during surgery 
Intra-operative  
Minimally invasive surgery if 
possible 
Yes Started Yes. ¾ surgeons 
do VATS (53% 
lobes done by 
VATS, June 
2012) 
Individualised goal-directed 
fluid therapy 
No No – some trustwide use 
in other specialities 
No 
 
 
Avoid crystalloid overload Yes ??? Yes 
Epidural management Yes Yes – use of 
epid/PVC/regional 
blocks 
Reducing 
number. PVC the 
norm. 
Use of regional/spinal and local 
anaesthetic with sedation 
Increasing use of 
PVC+PCA 
Yes PVC the norm 
Hypothermia prevention Yes Yes Yes 
 
 
 
The patient has the best possible management during surgery: 
 
There is a much greater degree of similarity between the three units in regard to their 
practices at the time of surgery. All three utilise minimally invasive surgery, use 
regional anaesthesia and prevent hypothermia.   
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Elements 
 
BIRMINGHAM MANCHESTER BRISTOL 
 
The patient experiences the best post-operative rehabilitation 
Post Operative  
No routine use of wound drains Yes Yes Yes 
Chest drain management Protocol- but 
?compliance 
100% rocket drains, 
usually only one 
One ICD as 
standard 
Active planned mobilisation 
within 24 hours 
Yes Planned, but patients in 
CTCCU so may not be 
mobilised 
Yes 
Early oral hydration Yes Yes Yes 
Early oral nutrition Yes Yes Yes 
IV therapy stopped early Yes, but Recovery 
ask for IVI 
Yes None prescribed 
Catheters removed early Yes Yes. Unusual to have 
catheter even with 
epidural 
Yes 
Regular oral analgesia e.g. 
paracetamol and NSAIDS 
Yes, but ?protocol 
compliance 
‘Hit & miss’. No protocol Yes, structured 
analgesic ladder 
Avoidance of systemic opiate-
based analgesia where 
possible 
Variety in analgesic 
techniques: 
Morphine infusion, 
PVC+PCA 
Yes Yes. PCA used 
with PVC. Taken 
down as early as 
possible 
Follow-up  
Discharge on planned day or 
when criteria met 
?Yes ? Yes. Consultant 
ward round daily 
Therapy support (Physio, 
Dietician) 
Yes ? Yes 
24 hour telephone follow-up 
call if appropriate 
No Have access. Phones 7-
21 days post surgery 
Yes. Called in 
first week post 
surgery  
 
The patient experiences the best possible post-operative rehabilitation: 
Post-operatively there are many similarities in practice between the three units. Early 
mobilisation, hydration and nutrition is standard whilst all units try and avoid 
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systematic opiate analgesia. After discharge two units, Manchester and Bristol 
contact their patients with a follow up telephone call. 
3.3 National survey  
3.3.1 Collation of results 
Eighty three individuals responded from thirty-four out of forty (85%) units performing 
thoracic surgery in UK.  Opinions from a range of healthcare professionals were 
recorded. The survey was conducted through a third party commercial partner and 
efforts to obtain the raw data were unsuccessful. Thus, exact details of total 
responder rate and response rate per healthcare professional from individual units in 
unknown. 
 
Survey summary: 
Areas of success identified included pulmonary rehabilitation before and after 
surgery, smoking cessation, nutritional optimisation, pre-operative assessment, 
optimising post-operative fluid management, early mobilisation and physiotherapy, 
digital drains and standardised pain protocol. However, admitting patients on the day 
of surgery, wider spread use of minimally invasive surgical techniques, minimising 
length of pre-operative starvation, provision of better quality patient information and 
post discharge care were areas with the poorest uptake within the UK. It is these 
areas where further promotion of ER practice could result in improved patient care. 
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3.3.1.1 Pre-operative assessment clinic (POAC)  
With regards to provision of pre-assessment, 79% of responding units utilise a POAC 
(27/34 units). The majority of units (16/27 or 59%) using POAC facilities review >75% 
of their thoracic surgical patients. However, only 9/27 units (33%) with POAC facilities 
have an available anaesthetist to review the patient. The consensus belief is that 
POAC benefits patients by preparing them better (96% responses) resulting in fewer 
cancellations (77%). 
 
3.3.1.2 Day-of-surgery admission (DOSA)  
Of the 26 units reporting to have a POAC, only 31% (8 units) actually admit their 
patients on the day of surgery. The commonest reasons reported as barriers to 
DOSA are outlined in Table 8. Space was also left for individuals to comment 
specifically on their units own circumstances to further elucidate the barriers to 
DOSA. 
 
Table 8: Reported barriers to day-of-surgery admission (DOSA). 
Barriers to DOSA Percentage 
No surgical admission suite 
 
83% 
Anaesthetist preference not to admit day of 
surgery 
61% 
No DOSA in unit or hospital 44% 
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Surgeon preference not to admit day of 
surgery 
44% 
Logistic/geographical 
 
17% 
3.3.1.3 Patient information  
The provision of thoracic specific patient information is high (94% units). It is 
predominantly in the form of written information (97% patients). However, only 71% 
units report that the information given is of good quality. Thus, the substantial 
remaining proportion of unit’s belief is that their patient information needs improving. 
 
3.3.1.4 Starvation prior to surgery  
The time of starvation before operation, nil-by-mouth (NBM) period, was assessed in 
terms of fluids and solids. Seventy-four per cent of units report starving patients of 
fluids between 2 – 6 hours before surgery. Thus, over a quarter of patients do not 
receive any oral fluid intake for greater than 6 hours prior to surgery. When 
questioned regarding their beliefs, nearly nine out of ten units (87%) reported that the 
perceived NBM period for fluids should be less than 6 hours. With regards to oral 
solids, 10% report a NBM period less than 6 hours, while approximately three 
quarters of units (77%) report patients being NBM for food for between 6 and 12 
hours before their operation. Ten per cent of units starve their patients for between 
12 and 24 hours.  This is in contrast to the reported beliefs, with 57% and 37% units 
believing the time should be 6 – 12 hours or less than six hours respectively. 
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3.3.1.5 Minimally invasive surgery  
Ninety-two per cent of units report performing minimally invasive surgery for major 
lung resection. Table 9 shows the areas in which responders believed minimally 
invasive surgery had improved patient care. 
 
Table 9. Areas of care in which units practicing VATS surgery had observed 
improvements. 
Areas of improvement Percentage reported (24 units) 
Reduced LOS 96% 
Improved patient satisfaction 92% 
Improvements in pain score 83% 
Reduced complications 67% 
Reduced ITU admissions 46% 
Reduced readmissions 42% 
 LOS, length of stay; ITU, intensive care unit 
 
3.3.1.6 Analgesia strategies  
Results of questions regarding analgesia strategies revealed a wide variety of 
practice in the UK. The most frequently reported methods undertaken were 
paravertebral catheters (PVC, 93% units), intravenous morphine infusion (90% units), 
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epidurals (73% units) and intra-thecal injections (10% units). Of the 28 units reporting 
the use of PVC, 16 (57%) placed them into >50% of patients.  
Eighty-three per cent of units report having a standardised pain control guideline or 
protocol. This has been written specifically for thoracic surgery in 63% of cases. 
These analgesia guidelines include the regular use of laxatives in 75% units and 
regular non-steroidal anti-inflammatory drug (NSAID) prescription in 26% units. 
 
3.3.1.7 Physiotherapy provision  
Of those units responding, 79% have standardised post-operative physiotherapy 
guidelines. In approximately two thirds of cases (69%) it is reported to be written 
specifically for thoracic surgical patients. Specific questioning regarding aspects of 
these guidelines were asked. These include sitting the patient out on day 1 post-
operatively (97% units) with a similar percentage (100%) of responders believing this 
to be best practice. Similarly, all responses (100%) believed mobilising the patient on 
day 1 was best practice, however only 86% units actually achieve this. 
 
3.3.1.8 Post-discharge follow up  
Ninety-seven per cent of units give patients thoracic surgery specific advice before 
discharge. This information is predominantly in the form of verbal advice (89% units) 
and written material (75% units). Further interventions included a patient diary (8% 
responding units) with patients receiving a DVD from 3% units.  
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Contact following discharge is achieved by 26% units, who telephone their patients 
within one week of discharge. In addition, two units (6%) report making home visits to 
patients after discharge. When responders were questioned regarding their beliefs, 
contact after discharge was seen to benefit patients in a number of ways. These 
include reduction in patient anxiety (95% responses), reduction in readmission rate 
(81%) and increased patient satisfaction (91%). Comments regarding post discharge 
follow up were also gathered. 
 
3.3.1.9 Dissemination of results  
The results of the survey were disseminated at the Enhanced Recovery session: 
Fulfilling the potential a better journey for patients a better deal for the NHS at 
Society for Cardiothoracic Surgery in Great Britain & Ireland, Annual Meeting 2013 in 
Brighton [Appendix 2]. 
 
 
3.4 Enhanced recovery pathway development 
Local guidelines have been drawn up, discussed, reviewed and amended by key 
stake holders. Key elements already established at Heartlands Hospital were 
augmented by evidence from the literature review and gap analyses (Figure 8).  
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Figure 8: ER pathway development 
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Review of Figure 8 reveals that a number of key ER elements are already in place at 
Heartlands Hospital (✓), whilst others are not (X). Construction of the ER manual 
highlighted three further areas that needed addressing at a local level (Future work 
on Figure 4), namely improved patient information a process to reduce pre-operative 
dehydration and a standardised analgesia protocol. 
 
This has led to the construction of our ERAS manual giving detail of each step and 
element within the thoracic ERAS programme at Birmingham Heartlands Hospital 
(Figure 9). 
 
 
Figure 9: Enhanced recovery in thoracic surgery- Birmingham Heartlands Hospital 
manual 
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The completed manual has been distributed to other thoracic surgical units interested 
in starting an ER programme. The manual is included in Appendix 2. 
 
 
3.5 Testing the pathway   
Since the launch of the ERAS programme at Heartlands Hospital in February 2013, 
the initial effect on number of deaths, LOS and PPC rate have been analysed. Data 
on 275 patients undergoing VATS lobectomy and 272 patients having a lobectomy 
via thoracotomy has been collected. This data is displayed in 1-year time intervals, 
starting 1 year before the introduction of the ERAS programme. 
 
Table 10: Patient demographics 
    
Total 
(n) 
Age (yrs)  
[mean +/- SD] 
Male  
[%] 
BMI (kg/m2)  
[mean +/- SD] 
FEV1 (L)  
[mean +/- SD] 
VATS Feb 12 - Jan 13 46 70.2 +/- 8.0 56.5 26.2 +/- 4.2 85.6 +/- 20.6 
  *Feb 13 - Jan 14 59 66.3 +/- 10.4 45.8 26.6 +/- 5.0 87.8 +/- 19.8 
  Feb 14 - Jan 15 78 67.5 +/- 11.4 53.8 26.4 +/- 5.4 86.2 +/- 17.6 
  Feb 15 - Jan 16 92 67.7 +/- 8.5 39.1 26.8 +/- 4.7 89.2 +/- 21.4 
           
Thoracotomy Feb 12 - Jan 13 75 67.5 +/- 9.4 50.7 26.8 +/- 5.2 87.4 +/- 21.2 
  *Feb 13 - Jan 14 78 66.8 +/- 10.0 52.6 27.0 +/- 5.8 89.2 +/- 20.5 
  Feb 14 - Jan 15 60 68.4 +/- 9.6 46.7 26.3 +/- 4.8 87.5 +/- 20.4 
  Feb 15 - Jan 16 59 67.7 +/- 11.9 61.0 27.2 +/- 4.6 86.7 +/- 21.0 
*:introduction of ERAS in February 2013 
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Table 11: Patient outcomes 
    
Total 
(n) 
Deaths  
(n) 
LOS (days)  
[median + IQR] 
PPC rate  
(n/%) 
VATS Feb 12 - Jan 13 46 0 4 (3 - 6) 3 (6.5%) 
  *Feb 13 - Jan 14 59 1 4 (3 - 6) 5 (8.5%) 
  Feb 14 - Jan 15 78 1 4 (3 - 5) 6 (7.7%) 
  Feb 15 - Jan 16 92 1 4 (3 - 5) 5 (5.4%) 
          
Thoracotomy Feb 12 - Jan 13 75 2 6 (5 - 9) 20 (26.7%) 
  *Feb 13 - Jan 14 78 0 6 (4 - 9) 10 (12.8%) 
  Feb 14 - Jan 15 60 2 6 (4 - 10) 12 (20.0%) 
  Feb 15 - Jan 16 59 2 6 (5 - 9) 7 (11.8%) 
*:introduction of ERAS in February 2013 
 
In the study period there is an almost equal number of patients undergoing VATS 
lobectomy as those having a thoracotomy. However, there is an increasing number 
of lobectomies for primary lung cancer being performed via minimally invasive 
approach [VATS]. Patient demographics are similar allowing comparison between 
the two surgical approaches. There are however more women undergoing VATS 
lobectomy as opposed to a thoracotomy in the latter study group [Feb 15 – Jan 16]. 
The outcomes show that LOS is stable and has not deteriorated since the 
introduction of ERAS. The number of patient deaths has also remained very low. 
There is a trend towards a reduction in PPC rates for patients undergoing a 
thoracotomy for primary lung cancer, which is not seen in the VATS group. 
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4 DISCUSSION & CONCLUSIONS  
Enhanced recovery in thoracic surgery is in its relative infancy. ER is not routinely 
practiced throughout the UK thoracic surgical community, but rather is concentrated 
in a handful of units. Even within the localised geographical region sampled, the unit 
visits and gap analyses highlighted variations in ER practice. Due to the large 
proportion of the workload being elective, non-emergency work, thoracic surgery 
lends itself to the application of ER principles and practice. ER can be applied to the 
entire patient journey, even within the relatively confined time pressure for cancer 
patients to undergo surgery.  
 
 
4.1 Review of the literature 
The review encompassed two elements of ER, management of intercostal chest 
drains after surgery and the use CHO loading supplements given prior to operative 
procedures. 
 
4.1.1 Chest drain management 
The way in which chest drains are managed after thoracic surgery has been 
extensively researched. Despite numerous papers being published on various 
aspects of chest drain management, there is still no consensus between surgical 
units or individual surgeons. The literature is summarised below:  
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• Digital drains superior to traditional underwater seal [48-50] 
• Drainage- ICDs can be removed once fluid quantity is less than 200ml/day 
[48,49,52,58], 250ml/day [50, 53], 400ml/24hrs [51] 
• Drain protocol advantageous [52] 
• Milking ICDs not advised [53] 
• Lobectomies- only one ICD favoured as compared with two [54, 55] 
• VATs lung biopsy- no ICD drain favoured when no intraoperative air leak 
detected [56,57] 
• Routine application of suction- not necessary post lung resection [58, 59] 
  
Digital drains, connected to the patient’s chest tube, are superior to the traditional 
underwater seal system. These permit earlier mobilisation, accurate display of air 
leak for the lung and have a number of built-in safety alarms. There remains however 
a wide variety in practice, within the literature, in terms of drain removal with regards 
to fluid drainage. Chest drains can be removed once fluid quantity ranges from less 
than 200ml/day to 400ml/day. This has led to the construction of a drain removal 
protocol in our unit to prevent drains being left in unnecessarily, which can carry 
significant patient morbidity. It also speeds up decision making for junior medical staff 
when it comes to making the decision to remove a drain. 
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4.1.2 Carbohydrate loading 
Although no papers were found to address the question of carbohydrate loading in 
thoracic surgical patients, there are a number of studies from other surgical 
specialities. In particular, there are several studies in gastrointestinal surgery. Five 
prospective randomised control trials have found several key advantages that could 
potentially benefit thoracic surgical patients. Improved gastrointestinal function, 
reduced loss of muscle mass and reduced LOS has been demonstrated in non-
thoracic surgical patients. There are also no reported disadvantages, and although 
supplying CHO drinks has a financial implication, overall they may also be cost-
effective providing savings in other areas. 
 
 
4.2 Current processes in thoracic surgery 
To capture the current practices in thoracic surgery an attempt was made to analyse 
three units with a wide experience of delivering ER. Interviews conducted at these 
units and analysis of the ER elements being employed, successful or otherwise, fed 
into information for the review. Combined with a national survey, the gap analyses 
fed forward enabling the construction of an ER programme at Heartlands Hospital.  
The objective of the ER survey was to evaluate the current state of ER practice in 
thoracic surgery within the UK. It captured, as accurately as possible, the practices 
and beliefs of a significant proportion of the total thoracic units within the UK. Eighty-
five percent of units undertaking thoracic surgery responded to the survey. 
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Responders included consultant surgeons, trainees, nurses and physiotherapists 
giving a broad perspective on each unit’s ER practice. The majority of units had pre-
operative assessment facilities, permitting day of surgery admission, but only a third 
had immediate anaesthetic input available. In the units with POAC only a third 
admitted patients on DOS, with barriers reported including surgeon or anaesthetist 
preference not to admit DOS, no DOSA unit and patient factors of geography or 
logistics. The ability to admit on DOS is a key element of ER and thus these 
deficiencies need addressing. Additionally, the starvation period prior to surgery 
merits improvement, as a quarter of patients are starved excessively of fluids and 
food. Performance of minimally invasive surgery for major lung resection was 
reported in 90% units surveyed, in stark contrast to national audit data showing only 
15% major lung resections being undertaken by VATS. Some of this disparity may be 
due to the audit data being three years old and thus failing to reflect a recent 
increase in the number of surgeons performing major resections by VATS. However, 
this difference remains large and can’t just be attributable to old data. With regards to 
analgesic strategies, the national picture is mixed, with most units reporting using a 
variety of techniques including epidurals, para-vertebral catheters and intravenous 
morphine. Encouragingly, the majority of units have a standardised post-operative 
physiotherapy protocol designed to reduce complications including sputum retention 
and lung collapse, chest infections and venous thromboembolism. Provision of 
patient information following discharge was very high, usually in written form, but one 
third of units believed the quality needed improving. 
This project has delivered the first national survey of ER practice in thoracic surgery. 
The results not only highlight the good practices of ER across the country but also 
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reveal areas for improvement. The key areas to address include reducing the period 
of pre-operative starvation, facilitating DOSA, increasing the number of major 
resections completed by VATS and promoting post-discharge contact with patients to 
reduce readmission rates and increase patient satisfaction. 
 
4.3 Enhanced Recovery in thoracic surgery 
Building on the processes and elements already in place, the ER manual constructed 
from the literature review, gap analysis and national survey led to the formulation of 
an ER pathway for thoracic surgical patients at Birmingham Heartlands Hospital. The 
manual also facilitates other thoracic units in constructing an ER pathway. 
The resultant pathway was formally introduced in February 2013. Prior to the start 
date key stakeholders had been informed (e.g. ward staff given presentation) and the 
process advertised in the thoracic surgical ward.  Having an established start 
enabled data to be collected and thus the effect of the pathway evaluated.  
Early indicators using the quantitative data collected suggest that there has been an 
increase in the utilisation of minimally invasive operative techniques and a reduction 
in post-operative complications, without an increase in patient mortality. These 
benefits reflect the published literature with regards to reduced LOS observed in 
several surgical specialities including colorectal [4-12,17-20], non-colorectal [27-30, 
34] and thoracic [39-42]. Similarly benefits of reduced post-operative complication 
rates, particularly pulmonary complications, observed in our data reflect the 
published literature [29,39,40,42]. These observed improvements we need to be 
consolidated and at this time no long-term data is available. The success, or 
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otherwise, of this ER programme will depend on the sustainability of these 
advantages. Additionally, improvements in patient reported outcome measures 
(PROMs) [12] and readmission rates [13-15,30], whilst reducing costs [4,21,22] have 
been reported. Data for these outcome measures will need to be collected in the 
future to evaluate the potential benefits of ER for thoracic surgical patients. 
 
4.4 Limitations 
Enhanced recovery in thoracic surgery 
The bulk of work undertaken in ER comes from non-thoracic surgical specialities. 
Initial experience in thoracic surgery has often involved borrowing and modifying 
these existing pathways prior to implementation. Some of the elements have needed 
to be changed or tailored towards thoracic surgical patients, but otherwise the 
principles remain the same. It is thus hoped that the benefits already established in 
other specialities can be applied to thoracic surgery. Logically, if it improves the care 
of non-thoracic surgical patients it must also benefit patients undergoing lung 
surgery. To this extent the first paper outlining an ER programme in thoracic surgery 
was published in 2016 [40].  
Overall, ER pathways can then be compared to the previous standard of care and 
benefits, or otherwise, can be measured. The difficulty comes when trying to assess 
the effect of individual ER components within an established programme. It is hardly 
ethical to start removing individual elements from an ER programme, to measure the 
effect of one component, if the entire pathway has been shown to convey an 
advantage. Thus, it is very difficult to measure the effect of single elements within an 
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established pathway, to identify which convey the biggest advantage. One approach 
would be to introduce every element one at a time and evaluate the effect. There are 
a number of difficulties with this approach, the most problematic being that each 
change is likely to only bring about a small improvement, too small to accurately 
measure. It is the sum of all these small improvements that gives patients in ER 
programmes maximal benefit. Conversely, the second approach would be to 
introduce ER wholesale and compare it to the previous standard of care, accepting 
that it is difficult to tease out the effect of individual elements. This has the advantage 
of being a simpler approach in terms of measuring outcomes, but again has 
difficulties. Adopting an entirely new way of working, and thinking about how patients 
are managed, can often be met with resistance. Going against an established dogma 
of practice can make changes difficult. Introducing smaller changes may be easier to 
accept. 
 
Study limitations 
There are a number of limitations to this study. This project has been constructed, 
analysed and completed by a solo PGR. It thus leaves the study open to a number of 
weaknesses. The literature review was conducted independently and is thus open to 
selection bias. Similarly the gap analysis was conducted by the PGR and may have 
been improved with training and experience of qualitative interview analysis. The 
survey was conducted by a third party and although the results were available, the 
raw data, including key indicators of quality (such as percentage response rate and 
response rate per healthcare professional type) was not. The ER pathway 
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construction was entirely healthcare professional led. There was a lack of patient 
involvement in pathway design and outcomes. The acceptability of ER was not 
investigated outside the sphere of healthcare professionals, nor was quality of life or 
quality of improvement measures taken into consideration. The pathway testing 
focused on more easily obtained quantitative outcome measures, whilst qualitative 
data was not obtained. The study could thus be enhanced by addressing these 
issues. 
 
Summary 
Despite the limitations with this study, I am convinced that adopting ER into thoracic 
surgery will only result in benefits for this patient group. Improving patient satisfaction 
alongside reduced complication rates, length of inpatient stay and readmission rates 
can only be advantageous. Building on the work from other surgical specialities, I 
believe the wider adoption of ER for thoracic surgical patients will result in improved 
patient care. 
 
 
5 FUTURE WORK  
There are several areas in which future work should focus. Locally, the 
implementation of dehydration prevention strategies and analgesia prescription can 
be audited and the effects evaluated. Then the decision can be made as to whether 
these two interventions should be retained as part of the ER programme. It is difficult 
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to tease out effect of individual elements as most pathways are imported wholesale. 
But within established pathways, new elements are more easily evaluated. For 
example, the production of a new thoracic surgery specific patient information booklet 
may be advantageous once introduced into an established ER programme. The 
effect on clinically relevant outcomes, as well as patient reported outcome measures, 
can be evaluated after its introduction. 
 
Future outcome measures 
Further work should encompass pain scores, time to first mobilisation, analysis of ER 
pathway completion rates, EP bundle usage and the implementation of preventing 
dehydration strategies. The alteration to starvation instructions prior to surgery has 
yet to be evaluated.  
It is hypothesised that the patient experience will be improved by reducing the 
unpleasant sensation of thirst prior to surgery, whilst reducing the amount of peri-
operative intravenous fluid needing to be administered. The impact of ‘My Lung 
Surgery Handbook’ (Appendix 4) has also yet to be analysed, as it is hypothesised 
that improving patient education will result in better clinical as well as patient reported 
outcome measures. 
Qualitative outcome measures including patient acceptance of ER pathway, quality of 
life and quality of information should also be investigated.  
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The Future 
Nationally, interest in ER is gathering. Speaking to colleagues in other units, 
highlighting the benefits to others and showcasing on a national stage will  push ER 
to the fore. However, changing the perception of others who may not believe in the 
benefits of ER and challenging surgical dogma will ultimately be the biggest test. This 
can be achieved, but will require evidence. The advantages of established thoracic 
surgery specific ER practice will have to  be demonstrated in the published literature. 
It will also be advantageous to identify the key elements bringing the biggest gains. 
Targeting future endeavours to these key areas will enable maximal improvements to 
patient care and resulting benefits to the NHS.  
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Hospital manual 
Appendix 3-  Electronic prescription for thoracic surgical patients- 6 new bundles to 
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APPENDIX 1: ENHANCED RECOVERY- FULFILLING THE POTENTIAL A 
BETTER JOURNEY FOR PATIENTS AND A BETTER DEAL FOR THE NHS 
[Society for Cardiothoracic Surgery in Great Britain & Ireland, Annual Meeting 2013] 
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APPENDIX 2- ENHANCED RECOVERY IN THORACIC SURGERY: BIRMINGHAM 
HEARTLANDS HOSPITAL MANUAL 
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APPENDIX 3: ELECTRONIC PRECRIPTION FOR THORACIC SURGICAL PATIENTS: 6 NEW BUNDLES [TO REPLACE 
EXISTING 2 BUNDLES] 
 
 
Drug group Thoracic bundle 
(epidural) 
Thoracic bundle  
(PVC) 
Thoracic bundle  
(Intra-thecal) 
Thoracic bundle  
(IV morphine infusion) 
Thoracic bundle  
(PCA) 
Thoracic bundle 
(PVC + IV morphine 
infusion) 
Analgesics Epidural 
 
PVC + PCA 
 
Intra-thecal inj + PCA IV morphine infusion IV morphine (PCA) PVC + IV morphine 
infusion 
 IV morphine in 
recovery 
IV morphine in 
recovery 
IV morphine in 
recovery 
IV morphine in 
recovery 
IV morphine in 
recovery 
Paracetamol 1g  
QDS REG PO/IV 
Paracetamol 1g  
QDS REG PO/IV 
Paracetamol 1g  
QDS REG PO/IV 
Paracetamol 1g  
QDS REG PO/IV 
Paracetamol 1g  
QDS REG PO/IV 
Paracetamol 1g 
QDS REG PO/IV 
Anti-emetics Cyclizine 50mg  
TDS PRN PO/IM/IV 
Cyclizine 50mg  
TDS PRN PO/IM/IV 
Cyclizine 50mg  
TDS PRN PO/IM/IV 
Cyclizine 50mg  
TDS PRN  PO/IM/IV 
Cyclizine 50mg  
TDS PRN  PO/IM/IV 
Cyclizine 50mg  
TDS PRN  PO/IM/IV 
Ondansetron 4mg 
QDS PRN PO/IV 
Ondansetron 4mg 
QDS PRN  PO/IV 
Ondansetron 4mg 
QDS PRN PO/IV 
Ondansetron 4mg 
QDS PRN PO/IV 
Ondansetron 4mg 
QDS PRN PO/IV 
Ondansetron 4mg 
QDS PRN PO/IV 
Laxatives Docusate Sodium 
100mg TDS REG PO  
Docusate Sodium 
100mg TDS REG PO  
Docusate Sodium 
100mg TDS REG PO  
Docusate Sodium 
100mg TDS REG PO  
Docusate Sodium 
100mg TDS REG PO  
Docusate Sodium 
100mg TDS REG PO  
Senna 15mg   
Nocte REG PO 
Senna 15mg   
Nocte REG PO 
Senna 15mg 
Nocte REG PO 
Senna 15mg 
Nocte REG PO 
Senna 15mg   
Nocte REG PO 
Senna 15mg   
Nocte REG PO 
Macrogol 1 sachet 
TDS  PRN PO 
Macrogol 1 sachet 
TDS  PRN PO 
Macrogol 1 sachet 
TDS PRN PO 
Macrogol 1 sachet 
TDS PRN PO 
Macrogol 1 sachet 
TDS PRN PO 
Macrogol 1 sachet 
TDS PRN PO 
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PCA- patient controlled analgesia 
PVC- paravertebral catheter 
 
 
 
 
 
VTE prophylaxis TEDS 1 pair TEDS 1 pair TEDS 1 pair TEDS 1 pair TEDS 1 pair TEDS 1 pair 
Nebulisers 0.9% Salbutamol 
2.5mg QDS  REG NEB  
0.9% Salbutamol 
2.5mg QDS  REG NEB  
0.9% Salbutamol 
2.5mg QDS  REG NEB  
0.9% Salbutamol 
2.5mg QDS  REG NEB  
0.9% Salbutamol 
2.5mg QDS  REG NEB  
0.9% Salbutamol 
2.5mg QDS  REG NEB  
0.9% Saline 5ml 2h  
REG NEB 
0.9% Saline 5ml 2h  
REG NEB 
0.9% Saline 5ml 2h 
REG  NEB 
0.9% Saline 5ml 2h  
REG NEB 
0.9% Saline 5ml 2h  
REG NEB 
0.9% Saline 5ml 2h  
REG NEB 
Respiratory 
depression 
Humidified oxygen 
(Aim sats 96%, unless 
known CO2 retainer 
aim 88-92%) 
Humidified oxygen 
(Aim sats 96%, unless 
known CO2 retainer 
aim 88-92%) 
Humidified oxygen 
(Aim sats 96%, unless 
known CO2 retainer 
aim 88-92%) 
Humidified oxygen 
(Aim sats 96%, unless 
known CO2 retainer 
aim 88-92%) 
Humidified oxygen 
(Aim sats 96%, unless 
known CO2 retainer 
aim 88-92%) 
Humidified oxygen 
(Aim sats 96%, unless 
known CO2 retainer 
aim 88-92%) 
Naloxone 400 
micrograms PRN (If 
resp rate < 8 breaths / 
min) 
Naloxone 400 
micrograms PRN (If 
resp rate < 8 breaths / 
min) 
Naloxone 400 
micrograms PRN (If 
resp rate < 8 breaths / 
min) 
Naloxone 400 
micrograms PRN (If 
resp rate < 8 breaths / 
min) 
Naloxone 400 
micrograms PRN (If 
resp rate < 8 breaths / 
min) 
Naloxone 400 
micrograms PRN (If 
resp rate < 8 breaths / 
min) 
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APPENDIX 4- MY LUNG SURGERY HANDBOOK  
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APPENDIX 5: LITERATURE SEARCH STRATEGIES FOR CHEST DRAIN 
MANAGEMENT AND CARBOHYDRATE LOADING 
 
Chest drain management 
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Carbohydrate loading 
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APPENDIX 6: GAP ANALYSES 
Abbreviations 
ERAS- enhanced recovery after surgery 
CTS- cardiothoracic surgery 
OPC- outpatient clinic 
DOSA- day of surgery admission 
POAC- pre-operative assessment clinic 
VATS- video assisted thorascopic surgery 
ECHO- echocardiography 
PFT- pulmonary function test 
UHSM- university hospital of south manchester 
R+D- research and development 
CQUIN- commissioning of quality innovation payment framework 
TAH- total abdominal hysterectomy 
LOS- length of stay 
UGI- upper gastrointestinal surgery 
EVAR- endovascular aortic aneurysm repair 
AAA- abdominal aortic aneurysm 
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1. The Enhanced Recovery Pathway – Gap Analysis Thoracic Surgery 
(BIRMINGHAM) 
 
Elements Current practice status Notes / actions Responsibility 
Getting the patient in best possible condition 
Primary Care Input  
Optimising Haemoglobin levels No   
Managing pre-existing co morbidities 
e.g. Diabetes/Hypertension 
No   
Pre-operative  
Health and Risk Assessment POAC   
Good Quality Patient Information POAC- quantity (too 
much) and quality (too 
detailed)  
  
Informed decision making Discussion in OPC   
Managing patient’s expectations of 
what will happen to them 
???   
Optimised health/medical condition ???   
Therapy Advice ???   
Carbohydrate loaded drinks (high 
energy drinks) 
No   
Maximising patients hydration ? Patient information 
may lead to excess 
dehydration 
  
Discharge Planning – expected date 
of discharge (EDD) 
? Given   
Admission  
Admit on day of surgery Yes   
Optimise fluid hydration Unclear- ?dehydrated 
prior to surgery. No pre-
op drinks or hydration 
  
Avoid routine use of sedative pre-
medication 
Yes   
Carbohydrate loaded drinks (high 
energy drinks) 
No   
Additional Actions 
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The patient has the best possible management during surgery 
Intra-operative  
Minimally invasive surgery if possible Yes   
Individualised goal-directed fluid 
therapy 
No   
Avoid crystalloid overload Yes   
Epidural management Yes   
Use of regional/spinal and local 
anaesthetic with sedation 
Increasing use of 
PVC+PCA 
  
Hypothermia prevention Yes   
 
 
 
Additional Actions 
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The patient experiences the best post-operative rehabilitation 
Post Operative  
No routine use of wound drains Yes   
Chest drain management Protocol- but 
?compliance 
  
Active planned mobilisation within 24 
hours 
Yes   
Early oral hydration Yes   
Early oral nutrition Yes   
IV therapy stopped early Yes, but Recovery ask 
for IVI 
  
Catheters removed early Yes   
Regular oral analgesia e.g. 
paracetamol and NSAIDS 
Yes, but ?protocol 
compliance 
  
Avoidance of systemic opiate-based 
analgesia where possible 
Variety in analgesic 
techniques: Morphine 
infusion, PVC+PCA 
  
Follow-up  
Discharge on planned day or when 
criteria met 
?Yes   
Therapy support (Physio, Dietician) Yes   
24 hour telephone follow-up call if 
appropriate 
No   
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2. ERAS Unit visit- Manchester (University Hospital of South Manchester) 
 
Event: Pulmonary rehabilitation for lung cancer patients 
Mr B Naidu and Mr R Wotton invited speakers 
Date: 11th October 2012 
 
 
Nurse-led CTS clinic for cardiothoracic patients:  
Discussion with Kath Hewitt (Nurse lead CTS) 
 
Staff:  2 Thoracic nurses, 3 cardiac nurses, 1 health care assistant 
2 permanent rooms in OPC 
5 days/week (Monday-Friday):  8am – 5pm 
Combined clinic- both cardiac and thoracic patients seen 
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Access: 
• Patient can phone direct 
• Ward referral 
• GP referral 
• From OPC 
 
Two major functions: 
1. Pre-operative assessment 
2. Outpatient review and management.  
E.g. 
• ICDs, inc Pleurex (for thoracic/respiratory/oncology patients) 
• Flutter bags (clamp after 3 weeks) 
• Wound review 
• VAC therapy 
• Histology results 
• GP advice 
 
 
104 
 
Day of surgery admission (DOSA) 
Not routine, admitted night before surgery 
Clerked in POAC 
Drug chart written on arrival or admission 
 
Barriers to DOSA: 
• Anaesthetists- prefer to see patient night before surgery 
• Ward nurses- some opposition ?reason 
A few patients go to admission lounge on day of surgery 
 
 
Pre-operative assessment clinic (POAC) 
Pre-admission controlled by CTS clinic 
UHSM has central POAC, but Thoracic surgery has control over own patient pool 
 
Plan:  
• Take POAC to local referring hospitals (Issues ?rooms/space,time,local 
expertise) 
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Pre-operative investigations: 
• X-match for VATS lobes/sleeve/pneumos/chest 
walls/decorts/pectus/thymus 
 
Anaesthetic input: 
• Available via email/telephone 
• Few cancellations on day of surgery 
o Occasionally need ECHO/PFTs 
 
 
ERAS at UHSM 
Discussion with Wendy Winn (ER lead nurse, UHSM) 
 
Background 
• Colorectal nurse seconded to ERAS for 6months initially (Funded by 
cancer network to kick start ERAS) 
• Now permanent position (Funded by R+D/Service transformation- pay 
salary) 
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ERAS implementation 
Started with colorectal 18 months ago 
• Ward driven 
 
Nursing staff confident to make decisions 
 
 
 
ER lead post established 
• Remit: 
o Independent of ward staff 
o Review practice and challenge decisions 
• Working group per speciality 
o Monthly meetings (Directorate manager, Lead consultant, 
Service facilitator, Ward manager, PT, OT (orthopaedics), Nurse 
specialist, POAC manager, Matron) 
  
POAC was colorectal on ward but now incorporated into central UHSM POAC  
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CQUINS 
7 ER CQUINS established: 
- For cancer patients in Colorectal, Gynaecology oncology (TAH), 
Urology (Cystectomy) 
 
• Communication of decision of plan to GP within 10 days 
• Communication of information to patient of decision within 10 days 
• See specialist nurse for review prior to admission 
• DOSA + SAS from 1/10/12 
• On ERAS pathway 
• On ERAS pathway on discharge summary 
• Contact with nurse specialist nurse post-surgery within 10 days 
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Planned roll-out 
• Urology  
o Two consultants: changed practice, technique to reduce surgical 
time. Subsequent LOS reduction (23 to 17 days)  
o Cystectomy 2012- achieved 
o Prostatectomy/nephrectomy Oct 2012 
 
• Vascular 
o EVAR/AAA ?date 
 
• UGI 
o New consultant (trained in Guildford- expert minimally invasive 
group) 
o Other 2 consultants keen to implement ERAS. Many principles 
adopted already. 
 
• Thoracic surgery 
o Drive to implement 
o Nil in place currently. 
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o But, Thoracic POAC independent and can thus more easily 
facilitate DOSA more easily 
o Meeting today to kick start ERAS 
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The Enhanced Recovery Pathway – Gap Analysis Thoracic Surgery 
(MANCHESTER 19/9/12) 
 
Elements Current practice status Notes / actions Responsibility 
Getting the patient in best possible condition 
Primary Care Input  
Optimising Haemoglobin levels No   
Managing pre-existing co 
morbidities e.g. 
Diabetes/Hypertension 
No   
Pre-operative  
Health and Risk Assessment Verbal by LCNS e.g. 
surgery info/VTE 
  
Good Quality Patient Information Verbal by LCNS e.g. 
surgery info/VTE 
  
Informed decision making Verbal discussion 
LCNS/OPC 
  
Managing patient’s expectations of 
what will happen to them 
Verbal discussion 
LCNS/OPC 
  
Optimised health/medical condition Too late   
Therapy Advice    
Carbohydrate loaded drinks (high 
energy drinks) 
No- no access   
Maximising patients hydration No   
Discharge Planning – expected date 
of discharge (EDD) 
Yes   
Admission  
Admit on day of surgery No- night before   
Optimise fluid hydration None   
Avoid routine use of sedative pre-
medication 
Yes   
Carbohydrate loaded drinks (high 
energy drinks) 
No   
Additional Actions 
Clinic and POAC separate 
Thoracic NS led clinic 
- Open door/drop-in service, mon-fri 9-5 
- Incorporates POAC/drain clinic/pleurex 
- Some paperwork inc EDD, contact numbers, post op info 
- No patient diary 
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The patient has the best possible management during surgery 
Intra-operative  
Minimally invasive surgery if 
possible 
Started   
Individualised goal-directed fluid 
therapy 
No- some trustwide use 
in other specialities 
  
Avoid crystalloid overload ???   
Epidural management Yes- use of 
epid/PVC/regional blocks 
  
Use of regional/spinal and local 
anaesthetic with sedation 
Yes   
Hypothermia prevention Yes   
 
 
 
Additional Actions 
All patients go to CTCCU (CTS ITU/HDU)  
- Includes cardiac/ECMO/transplants for min.24hrs 
- If full leads to cancelled lists 
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The patient experiences the best post-operative rehabilitation 
Post Operative  
No routine use of wound drains Yes   
Chest drain management 100% rocket drains, 
usually only one 
  
Active planned mobilisation within 
24 hours 
Planned, but patients in 
CTCCU so may not be 
mobilised 
  
Early oral hydration Yes   
Early oral nutrition Yes   
IV therapy stopped early Yes   
Catheters removed early Yes. Unusual to have 
catheter even with 
epidural 
  
Regular oral analgesia e.g. 
paracetamol and NSAIDS 
‘Hit & miss’. No protocol.   
Avoidance of systemic opiate-based 
analgesia where possible 
Yes   
Follow-up  
Discharge on planned day or when 
criteria met 
?   
Therapy support (Physio, Dietician) ?   
24 hour telephone follow-up call if 
appropriate 
Have access. Phones 7-
21 days post surgery 
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3. The Enhanced Recovery Pathway – Gap Analysis Thoracic Surgery 
(BRISTOL) 
 
Elements Current practice status 
Notes / 
actions 
Responsibility 
Getting the patient in best possible condition 
Primary Care Input  
Optimising Haemoglobin levels POAC identifies problems   
Managing pre-existing co morbidities 
e.g. Diabetes/Hypertension 
POAC identifies problems   
Pre-operative  
Health and Risk Assessment OPC+POAC same day 
POAC has on hand 
anaesthetic consultants to 
review pts 
  
Good Quality Patient Information Patient diary 
EDD given 
  
Informed decision making Consent form (unsigned) 
given to patient to take 
home and read. Brings on 
DOSA 
  
Managing patient’s expectations of 
what will happen to them 
See above   
Optimised health/medical condition POAC   
Therapy Advice    
Carbohydrate loaded drinks (high 
energy drinks) 
Yes. 2/7 pre surgery 
High CHO on day of 
surgery 
7/7 post surgery 
  
Maximising patients hydration Can drink water until 2hrs 
prior to surgery 
  
Discharge Planning – expected date 
of discharge (EDD) 
Given to patient in OPC   
Admission  
Admit on day of surgery Yes. Routine   
Optimise fluid hydration Water until 2hrs prior to 
surgery 
  
Avoid routine use of sedative pre-
medication 
Yes   
Carbohydrate loaded drinks (high 
energy drinks) 
Yes   
Additional Actions 
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The patient has the best possible management during surgery 
Intra-operative  
Minimally invasive surgery if possible Yes. ¾ surgeons do VATS 
(53% lobes done by VATS, 
June 2012) 
  
Individualised goal-directed fluid 
therapy 
No   
Avoid crystalloid overload Yes   
Epidural management Reducing number. PVC the 
norm.  
  
Use of regional/spinal and local 
anaesthetic with sedation 
PVC the norm   
Hypothermia prevention Yes   
 
 
 
Additional Actions 
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The patient experiences the best post-operative rehabilitation 
Post Operative  
No routine use of wound drains Yes   
Chest drain management One ICD as standard   
Active planned mobilisation within 24 
hours 
Yes   
Early oral hydration Yes   
Early oral nutrition Yes   
IV therapy stopped early None prescribed   
Catheters removed early Yes   
Regular oral analgesia e.g. 
paracetamol and NSAIDS 
Yes, structured analgesic 
ladder 
  
Avoidance of systemic opiate-based 
analgesia where possible 
Yes. PCA used with PVC. 
Taken down as early as 
possible 
  
Follow-up  
Discharge on planned day or when 
criteria met 
Yes. Consultant led WR 
everyday 
  
Therapy support (Physio, Dietician) Yes   
24 hour telephone follow-up call if 
appropriate 
Yes. Called in first week 
post surgery 
  
 
 
 
 
 
 
